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Abstract   30 
There is an increased interest on secondary plant metabolites, such as polyphenols and 31 
carotenoids, due to their proposed health benefits. This attention includes their 32 
bioavailability, a prerequisite for assigning further physiological functions. As human 33 
studies are time-consuming, costly, and restricted by ethical concerns, in vitro models 34 
for investigating changes of these compounds during digestion have been developed and 35 
employed for predicting their release from the food matrix (bioaccessibility) and 36 
changes in their profiles prior to absorption. 37 
Most typically, models simulate digestion in the oral cavity, the stomach, the small 38 
intestine, and, occasionally, the large intestine. A plethora of models have been 39 
reported, the choice mostly driven by the type of phytochemical studied, whether the 40 
purpose is screening or studying under close physiological conditions, and the 41 
availability of the model systems. Unfortunately, the diversity of model conditions has 42 
hampered the possibility to compare results across different studies. For example, there 43 
is substantial variability in the time of digestion, concentrations of salts, enzymes, and 44 
bile acids used, pH, the inclusion of various digestion stages; and whether chosen 45 
conditions are static; (with fixed concentrations of enzymes, bile salts, digesta, and so 46 
on) or dynamic (varying concentrations of these constituents). This review presents an 47 
overview of models that have been employed to study the digestion of both lipophilic 48 
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and hydrophilic phytochemicals (to compare digestive conditions in vitro and in vivo) 49 
and, finally, recommends a set of parameters for both static and dynamic models that 50 
resemble physiological conditions.  51 
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Introduction  130 
  131 
Phytochemicals are a large and structurally diverse group of secondary plant 132 
metabolites that are non essential for humans, that is, their non consumption does not 133 
cause any specific deficiency symptoms. For the plant, these are also non essential 134 
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compounds, but they aid, among others, in fending off herbivores (polyphenols), or 135 
stabilizing photosynthetic pigments (carotenoids). From a chemical point of view, 136 
phytochemicals include very diverse compounds, from the rather polar polyphenols, to 137 
the rather non polar carotenoids, phytosterols, and terpenes.  138 
There has been increased interest  in phytochemicals as their consumption and body 139 
tissue levels have been associated with several health benefits, especially in relation to 140 
the prevention of chronic diseases such as diabetes, cancer, cardiovascular diseases 141 
(CVD) and neurodegenerative diseases (Krzyzanowska and others 2010). This is 142 
especially true for their consumption of whole fruits and vegetables, even though there 143 
is controversy about the compounds and mechanisms responsible for the observed 144 
health benefits. Nevertheless, a number of prospective studies have related the 145 
consumption of phytochemicals, such as of polyphenols and carotenoids, to whole fruits 146 
or vegetables with the prevention of chronic diseases (He and others 2007; Carter and 147 
others 2010). For example, in various meta-analyses, the consumption of carotenoids 148 
and several types of polyphenols such as flavonoids were inversely related to the 149 
incidence of CVD (Arts and Hollman 2005; Hamer and Chida 2007).  150 
The biological response of the human body to phytochemicals is greatly determined 151 
by the bioavailability of these bioactive molecules. The most abundant phytochemicals 152 
in our diet are not necessarily those able to result in the highest tissue concentrations or 153 
those revealing biological effects, owing to considerable differences in bioavailability 154 
(Manach and others 2005). Phytochemical bioavailability depends on a large number of 155 
factors and may differ according to the types of compounds studied, their differing 156 
associations with the plant matrix, variation in polarity, molecular mass, presence in 157 
crystalline or amorphous state, digestion by gastrointestinal enzymes, active vs. passive 158 
absorption into the enterocytes, and many more. Among the most important factors 159 
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determining bioavailability, and a prerequisite for intestinal absorption, is release from 160 
the food matrix and solubilization during digestion, also termed bioaccessibility (Parada 161 
and Aguilera 2007), which is therefore describing the fraction of a compound 162 
potentially available for further uptake and absorption. The amount of any 163 
phytochemical released and therefore potentially available for further absorption may 164 
differ greatly from its total concentration in the native food matrix. For some 165 
compounds that are poorly released and solubilized, such as carotenoids (Bohn 2008), 166 
or that are degraded prior to reaching their site of absorption, such as anthocyanins, the 167 
portion that is bioaccessible may be below 10% (Minekus 1995; Bouayed and others 168 
2011). Thus, a thorough understanding of changes occurring during digestion (such as 169 
mechanical action, enzymatic activities, and altered pH) is crucial for the understanding 170 
of bioaccessibility and estimating bioavailability and bioactivity, as only bioavailable 171 
phytochemicals will exert fully their potential beneficial effects. Because animal and 172 
human studies are very lenhtly and costly to conduct, and also have limitations due to 173 
ethical considerations, in vitro systems have been developed that enable the prediction 174 
of phytochemical changes during oral and gastro-intestinal digestion. This has allowed 175 
the screening of comparatively large numbers of samples and/or conditions, studying 176 
the separate and combined impacts of each stage of digestion on the release and 177 
availability of phytochemicals, which would hardly be possible in vivo.    178 
A major obstacle for the interpretation of phytochemical bioaccessibility based on in 179 
vitro studies is the large number of models published and presented in the scientific 180 
literature since the description of the first model developed for studying iron 181 
bioaccessibility (Miller and others 1981). The diversity of models has hampered the 182 
comparison of results across studies, and increased the chances of finding contradictory 183 
results. The employed models mainly differ in the inclusion of various stages of 184 
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digestion (oral, gastric, small intestinal, large intestinal); digestion times (typically 185 
ranging from a few minutes per stage to up to 3 h); pH; the nature of digestive enzymes 186 
involved and concentrations of salts and bile acids. Finally, while most of the models 187 
are operated in static conditions, that is with pre-fixed concentrations and volumes of 188 
digested materials, enzymes, salts etc.  (though during digestion phases are mixed and 189 
concentrations may change), there are also a limited number of continuous models that 190 
mimic the dynamic changes of the physicochemical conditions (and go along with a 191 
more constant change of digested material enzymes, salts etc. during various phases of 192 
digestion), and which aim to better simulate the passage of the bolus/digesta through the 193 
human digestive tract. However, these models are much more labor- and cost-intensive 194 
than the batch models.   195 
The aim of this review is to summarize frequently employed models for studying 196 
phytochemical bioaccessibility, to compare conditions to the situation in vivo, and to 197 
suggest a set of variables and values that appear closest to conditions in vivo, in order to 198 
contribute to the standardization of in vitro models. One of the major differences 199 
between the reported models, apart from being static or dynamic, is their application to 200 
either hydrophilic or lipophilic compounds (Figure 1).  201 
For practical reasons, this review focuses on 2 major groups of phytochemicals: 202 
polyphenols as the major water-soluble phytochemicals and carotenoids, as the major 203 
lipid-soluble phytochemicals, aiming to elucidate factors affecting the choices of the 204 
appropriate model for each application, in order to simulate in vivo conditions to the 205 
best of present knowledge. Thus, the review is structured, first, into a discussion of 206 
general digestion considerations, then to provide more thorough insights into the 207 
individual digestion phases themselves.  208 
 209 
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Parameters that drive the choice of model 210 
 211 
There are a number of factors that drive the choice of a model system (Figure 1). The 212 
most important is the desired outcome of the study. In some studies, the prime objective 213 
is to understand the effect of simulated gastrointestinal digestion on a certain class of 214 
phytochemicals (hydrophilic or lipophilic). For a limited selection of samples, in-depth 215 
simulation of a dynamic system may be more appropriate as it allows simulation of the 216 
effects of multiple digestive parameters on a small number of samples. Larger-scale 217 
studies may require screening of the effect of in vitro digestion on multiple samples 218 
(such as different source materials or the effects of processing/cooking) and a relatively 219 
simple static model may be more appropriate (Figure. 1).  220 
In some cases, the function of in vitro digestion is to provide samples that are more 221 
physiologically-relevant for further studies on potential bioactivities, as with the 222 
preparation of “colon-available” samples for effects on colon cancer models (Brown 223 
and others 2012) or the preparation of dietary fiber fractions such as -glucans (Beer 224 
and others 1997). 225 
Of course, there is considerable flexibility in the approaches. Initial hypotheses could 226 
be tested in the static models and then extended in dynamic model experiments; and 227 
insights gained from dynamic models could be fed back into the design of 228 
morephysiologically appropriate screening methods (Figure 1). 229 
 230 
Overview on parameters affecting the release and chemical changes of lipophilic 231 
and hydrophilic phytochemicals during digestion  232 
 233 
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Digestion of phytochemicals is a complex process, and the bioaccessibility of 234 
phytochemicals depends on both the characteristics of the food matrix and the 235 
physiological conditions encountered in the various compartments of the 236 
gastrointestinal tract (including enzyme concentration and pH). Additionally, the 237 
physicochemical properties of the phytochemicals themselves are important parameters. 238 
For example, the hydrophilicity/lipophilicity balance is crucial in driving the 239 
solubilization of hydrophilic phenolic compounds into the aqueous phase of the 240 
intestinal digesta and the restructuring of lipophilic carotenoids into mixed micelles.  241 
Since plant foods are often divers in composition or eaten in conjugation with other 242 
foods, food bolus constituents are likely to modulate the bioaccessibility and stability of 243 
phytochemicals. This may contribute to the rather small fraction of dietary 244 
phytochemicals that is typically absorbed and utilized by humans (Schramm and others 245 
2003). Therefore, defining the conditions that influence their absorption can provide 246 
significant insights into methods for maximizing the utilization of these sometimes 247 
health-promoting constituents. The main food components are proteins, carbohydrates, 248 
fiber, and fat, and their interactions with phytochemicals are often not considered. When 249 
considering in vitro bioaccessibility studies, chemical reactions (such as 250 
oxidation/reduction, complexation), biochemical reactions (enzyme/substrate 251 
interaction), or physical constraints (diffusion) occuring within food must be taken into 252 
account. For polyphenols, in particular, these types of interactions have rarely been 253 
taken into account when determining polyphenol digestion (Ortega and others 2009). 254 
 255 
Lipophilic phytochemicals 256 
Although carotenoids are lipophilic compounds and considered as relatively labile 257 
under acidic conditions, no significant chemical modification in the human stomach has 258 
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been described (Tyssandier and others 2003). Some isomerization was observed in the 259 
stomach of ferrets (Boileau and others 1999) and relatively high recoveries of dietary 260 
carotenoids (65-91%) have been observed after gastrointestinal in vitro digestion 261 
(Granado-Lorencio and others 2007; Failla and others 2009). The digestive stability of 262 
carotenoids in different food matrices has been investigated in a dynamic in vitro model 263 
simulating the stomach and small intestine (TIM 1) (Blanquet-Diot and others 2009; 264 
Déat and others 2009). Zeaxanthin and lutein (xanthophylls) were found to be stable 265 
during the whole digestion, whereas lycopene and -carotene (carotenes) were stable in 266 
the gastric and duodenal compartments but partly degraded in the jejunal and ileal 267 
compartments of the small intestine, perhaps due to delayed release from the matrix and 268 
later micellarization at this stage of these carotenes (Blanquet-Diot and others 2009). 269 
Although an enhanced release from the matrix can contribute to higher bioaccessibility, 270 
the released carotenoids may be more susceptible to degradation and isomerization 271 
(Failla and others 2008a). In the study by Blanquet-Diot and others (2009), a 272 
degradation of -carotene and all-trans lycopene, which could not be directly linked 273 
with the formation of cis isomers, was observed in the lowest part of the small intestine. 274 
As suggested by the authors, the results might to be due to breakdown to non-detected 275 
metabolites (such as oxidation products) or enzyme–catalyzed cleavage products during 276 
small intestinal digestion, but no precise data could support this hypothesis. The 277 
absorption of lipophilic phytochemicals mainly occurs after the disruption of the food 278 
matrix, enabling the release and emulsification into lipid droplets in the stomach, 279 
followed by incorporation into mixed micelles. Apart from the food matrix, carotenoid 280 
bioavailability may be influenced by the presence of other nutrients and non nutrients 281 
within the food. For example, a competition between carotenoids and other fat-soluble 282 
nutrients such as vitamin E at the absorption stage has been reported (Faulks and others 283 
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1998).  Differences in location and form will also affect carotenoid release and 284 
bioavailability. Carotenoids are usually associated with proteins, for example, lutein in 285 
green leafy vegetables is located in chloroplasts, whereas carotenes are found in 286 
chloroplasts in oil droplets, such as in fruits or semi-crystalline membrane-bound solids 287 
like in carrot, tomato, and papaya (Faulks and others 1998, Schweiggert and others 288 
2011).  289 
The effect of physicochemical properties on carotenoid bioaccessibility and transport 290 
to storage tissues was recently studied by Sy and others (2012a). The efficiency by 291 
which pure carotenoids were transferred from dietary lipids into synthetic mixed 292 
micelles was assessed using a modified method of the in vitro digestion model 293 
developed by Garrett and others (1999). Sy and others (2012a) found that lutein was 294 
more readily micellarized than the other carotenoids and especially compared with 295 
lycopene, which was the least micellarized carotenoid. The apparent poor solubility and 296 
bioaccessibility of lycopene may be due to its elongated shape that could cause the 297 
molecule to protrude from the micelles into the surrounding aqueous environment and 298 
similar effects could be expected for other lipophilic phytochemicals.  299 
 300 
Hydrophilic phytochemicals 301 
Phenolic phytochemicals can greatly vary in their chemical structure and properties, 302 
ranging from simple molecules (such as phenolic acids) to highly polymerized 303 
molecules (proanthocyanidins) (Manach and others 2004). This chemodiversity results 304 
in different bioaccessibility. Factors in the bioaccessibility of polyphenols include the 305 
release from the food matrix, particle size, the hydrophilic/lipophilic balance as related 306 
to their glycosylation, different pH-dependent transformations (degradation, 307 
epimerization, hydrolysis and oxidation during gastrointestinal digestion), and also 308 
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interactions between polyphenols and food components (Stahl and others 2002; 309 
Karakaya 2004). Phenolic compounds can have strong affinities with human salivary 310 
proline- and histidine-rich proteins and form both non covalent and covalent 311 
associations depending on the size of the phenolic compound (de Freitas and Mateus 312 
2001; Wroblewski and others 2001). High-molecular-weight polyphenols (such as 313 
tannins) interact strongly with fibers and proteins, but their affinity is related to their 314 
size and their solubility in water.  315 
More hydrophobic compounds have stronger binding to proteins (Le Bourvellec and 316 
Renard 2011). Laurent and others (2007) investigated the behavior of low molecular 317 
weight flavonoids from grape seed extract during in vitro digestion (with -amylase 318 
from human saliva, porcine pepsin, pancreatin and bile extract), combined with a Caco-319 
2 cell model to evaluate the impact of brush border proteins. Their results showed that 320 
flavan-3-ol monomers ((+)-catechin and (−)-epicatechin) and procyanidin dimers (B2 321 
and B3) were stable during oral and gastric digestion but those interactions with 322 
proteins occurred during the intestinal step with pancreatic digestion, and in the 323 
presence of brush border cell proteins. Simulated digestion of anthocyanins from, for 324 
example, red berries, red wine, and red cabbage have shown that these compounds 325 
appear to be stable at the acidic conditions of the stomach but less stable at the small 326 
intestinal pH (Gil-Izquierdo and others 2002; McDougall and others 2005a, 2007). The 327 
total recovery of anthocyanins from red cabbage was low (around 25%), possibly due to 328 
degradation into new phenolic components by the combination of the elevated pH and 329 
the presence of oxygen during pancreatic digestion (McDougall and others 2007).  As 330 
recently shown in the investigation by Oidtmann and others (2012), a possible mean to 331 
enhance the stability and protect anthocyanins from degradation in the small intestine 332 
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might be to use encapsulation techniques, such as microcapsule systems composed of 333 
polysaccharide pectin amide with or without shellac coating or whey proteins. 334 
In summary, the digestive stability of carotenoids depends on the molecular nature 335 
and the food matrix in which they are included, with xanthophylls being more stable 336 
than carotenes. The absorption of carotenoids depends on an efficient release from the 337 
food matrix and subsequent solubilization in mixed micelles. By contrast, no 338 
micellarization is required prior to cellular uptake for phenolic compounds, and, thus, 339 
there are possibly fewer possibilities for impacting bioaccessibility such as by varying 340 
enzyme concentrations; however, some constituents such as anthocyanins may be 341 
rapidly degraded due to increasing pH (McDougall and others 2007). The affinity of 342 
polyphenols for proteins (Dangles and Dufour 2005, 2008) may lead to a major 343 
modulation of both polyphenol absorption and reactivity in the stomach and in the upper 344 
intestine. 345 
 346 
Before modeling: Considerations with respect to pre treatments, meal size, and 347 
choice of test meals  348 
 349 
Food composition, how it is processed and the interaction of phytochemicals with 350 
other food components (be they lipophilic or hydrophilic), may modify the amount of 351 
phytochemicals released from the food matrix and, therefore, potentially increase or 352 
decrease their bioaccessibility.  353 
Influence of the plant matrix and food bolus 354 
Plant cell walls acts as a barrier to digestion (Ellis and others 2004; Mandalari and 355 
others 2010). When a plant cell is broken through mastication or crushing in industrial 356 
or domestic processing, phytochemicals may associate with dietary fibers leading to a 357 
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modulation of their relative bioaccessibilities. In a recent study, comparing the stability 358 
and bioaccessibility of carotenoids in pure forms (synthetic -carotene or retinyl 359 
palmitate solution) or from food (carrot juice and raw or cooked spinach), Courraud and 360 
others (2013) demonstrated the protective effect of the food matrix on dietary 361 
carotenoids. Their results showed that vitamin A and carotenoid standards (synthetic -362 
carotene or retinyl palmitate solution) were unstable, whereas food carotenoids were 363 
generally better protected by the food matrix (30-100% recovery versus 7-30% for 364 
standards). Although the susceptibility of carotenoids to degradation and isomerization 365 
has been found to increase after their release from the food matrix (Failla and others 366 
2008b), interactions with other compounds released from the food matrix (including  367 
soluble fibers) and viscosity may affect their bioaccessibility (McClements and others 368 
2008; Schweiggert and others 2012). For example, the bioaccessibility of β-carotene is 369 
known to be influenced by strong binding to pectins (Ornelas-Paz and others 2008).  370 
Dietary fibers are the main carriers for phenolic compounds and thus influence their 371 
bioaccessibility, as fiber-entrapped polyphenols are both poorly extractable and barely 372 
soluble in the GI fluids. High-molecular-weight proanthocyanidins and hydrolyzable 373 
tannins which represent more than 75% of all food polyphenols ingested (Arranz and 374 
others 2010) may bind tightly to dietary fibers and this restricts their accessibility. 375 
Soluble and insoluble polysaccharides can bind phenolic compounds and limit their 376 
diffusion, they increase the medium viscosity, and limit substrate-enzyme contacts 377 
during GI digestion (Eastwood and Morris 1992). During the in vitro digestion of cocoa 378 
powder, protease and glycosidase actions as well as gut microflora activity were shown 379 
to take part in the release of flavanols from matrix fibers and proteins (Fogliano and 380 
others 2011). Additionally, the extractability of phenolic acids, flavonoids, and 381 
proanthocyanidins appeared to be improved in the presence of fat, increasing by a 1.5-3 382 
 
 
16
factor for cocoa liquor (50% fat content) compared to cocoa powder (15% fat content) 383 
(Ortega and others  2009). 384 
The affinity of milk and egg proteins as well as gelatins for polyphenols depends on 385 
both the protein and phenolic structures (Bohin and others 2012). For example, 386 
chlorogenic acid associates with milk caseins rather than with β-lactoglobulin and this 387 
complexation was relatively stable in simulated gastric and intestinal steps (Dupas and 388 
others 2006). Despite these interactions, chlorogenic acid absorption by Caco-2 cells 389 
and rats was not reduced by milk addition to coffee. In tea, more than 60% of green tea 390 
flavanols (such as ECG, EGC, and EGCG), which are very prone to oxidation, 391 
disappeared in the intestinal phase during in vitro digestion (Haratifar and Corredig 392 
2014). A protective effect was caused by the addition of pure ascorbic acid, by citrus 393 
juices as well as by bovine, rice, and soy milks. While ascorbic acid contribution 394 
reflects its superior antioxidant capacity compared to tea flavanols, the protection by 395 
proteins was partially reversed by increasing the content of digestive enzymes, 396 
suggesting non covalent interactions between bovine milk proteins and galloylated tea 397 
flavanols (Green and others 2007).  398 
Soy isoflavones appear to be more bioaccessible from fruit juices and chocolate bars 399 
compared to cookies in in vitro conditions, perhaps due to their lower diffusion rate 400 
from the carbohydrate/protein matrix of the cookies (de Pascual-Teresa and others 401 
2006). However, a complementary human intervention study did not point out any 402 
significant difference in the bioavailability parameters (AUC, tmax or cmax) of these 403 
isoflavones. Similarly, the in vitro biacessibility of catechin recoveries was significantly 404 
higher in beverages than in confections (Neilson and others 2009). Higher amounts of 405 
isoflavones were also released in vitro from custards thickened with starch rather than 406 
with carboxymethylcellulose (Sanz and Luyten 2006). This effect was attributed to the 407 
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hydrolysis of starch by α-amylase which occurs from the mouth to the intestine. Finally, 408 
bile salts improved the in vitro bioaccessibility of isoflavone aglycones from soy bread 409 
through micellarization of these poorly-soluble molecules concentrations appeared to be 410 
a critical factor in the bioaccessibility of isoflavones from soy bread (Walsh and others 411 
2003). 412 
 413 
Impact of processing  414 
Previous studies (Garrett and others 1999) have indicated that food processing and 415 
dietary fat can enhance carotenoid bioaccessibility.  However, it is notablethat only a 416 
little proportion of carotenoids (5-25%) is efficiently liberated from the food matrix. 417 
Cooking and heat treatment may enhance carotenoid bioaccessibility due to disruption 418 
of plant tissue and denaturation of carotenoid-protein complexes which enhance release 419 
from the food matrix (Veda and others 2006; Failla and others 2009; Aherne and others 420 
2010). However, cooking enhanced the bioaccessibility and bioavailability of all-trans 421 
-carotenes but also caused carotenoid isomerization (Aherne and others 2010).  422 
There are many reports describing that thermal processing improves lycopene 423 
bioaccessibility due to the breakdown of the tomato matrix (Gartner and others 1997; 424 
Porrini and others 1998; Van Het Hof and others 2000). However, depending on the 425 
processing methods, differences in lycopene bioaccessibility have been reported. 426 
Yilmaz and Karakaya (2007) reported that lycopene bioaccessibility in raw tomato 427 
(29%) and canned tomato were similar (22%). On the other hand, bioaccessibility of 428 
lycopene from sun-dried tomatoes reached 58% (Yilmaz and Karakaya (2007). High-429 
pressure homogenization (HPH) and HPH combined with heat processing (90 C for 30 430 
min) caused a decrease in the in vitro bioaccessibility of lycopene. In addition, an 431 
inverse relationship between the homogenization pressure and lycopene in vitro 432 
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bioaccessibility was reported (Colle and others 2010). It was suggested that the fiber 433 
network formed by HPH entrapped lycopene, making it less accessible for digestive 434 
enzymes and bile salts. High-pressure processing (HPP), however, had no effect on -435 
carotene and -carotene bioaccessibility in carrots. Lutein bioaccessibility in green 436 
beans was increased by pressure treatment at 600 MPa (p<0.05), whereas -carotene 437 
bioaccessibility was reduced by HPP at both 400 or 600 MPa (McInerney and others 438 
2007), which suggests effects due to the matrix and compound structure. 439 
In wheat bran, ferulic acid and para-coumaric acid are mostly bound to 440 
arabinoxylans and lignin and are thus insoluble, whereas sinapic acid is mainly found in 441 
soluble conjugate forms esterified to sugars and other compounds . It was reported that 442 
the bioaccessibility of sinapic acid from bran-rich breads was much higher than that of 443 
ferulic acid and para-coumaric acid  (Hemery and others 2010). Food processing, 444 
especially grinding of the bran fractions, increased the bioaccessibility of phenolic 445 
acids. (Hemery and others 2010). This increase in bioaccessibility was correlated to the 446 
presence of very small particles (diameter < 20 µm) for sinapic acid and ferulic acid and 447 
that of larger particles for para-coumaric acid (between 20 and 100 m). Additionally 448 
to particle size reduction, exogenous ferulase and xylanase treatments contributed to the 449 
pool of free and exposed ferulic acid  residues as demonstrated by the increased 450 
antioxidant capacity displayed by treated fractions in an in vitro model of digestion 451 
(Rosa and others 2013a, b).  452 
 453 
Impact of starting meal size 454 
Adjustment of the ratio of the amount of the test meal to water present to mimic 455 
dietary bolus during digestion phases has an impact on viscosity. Both this ratio and 456 
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meal particle size are important factors influencing phytochemical release during 457 
digestion.  458 
During transit in the oral cavity, the stomach, and the small intestinal compartments, the 459 
dietary bolus will be diluted as a consequence of addition of saliva and other secretions. 460 
The amount and type of food influence the composition and secretion rates. Apart from 461 
the volume and composition of the secretions, mechanical forces will also have an 462 
impact on the disintegration and dissolution of a meal and on the rate of transfer through 463 
the GI tract. In general, dynamic models are able to process complex foods through 464 
mechanical and enzymatic digestions at volumes equivalent to “standard” meals. 465 
 466 
Digestion models for studying phytochemical bioaccessibility - static vs. dynamic 467 
models  468 
 469 
Depending on the type of research question, for example, if constituting a screening 470 
application or a confirmative study, the type and amount of sample present, static or 471 
dynamic in vitro models can be used to simulate different phases of digestion (Figure 472 
1).  Practically, static models provide a feasible and inexpensive means to assess 473 
multiple experimental conditions, allowing large numbers of substrates to be tested. 474 
Dynamic multistage continuous models facilitate long-term studies and probably come 475 
closest to in vivo conditions. These complex computer controlled systems, however, are 476 
expensive to set up, more labor-intense and time-consuming (maximum one experiment 477 
/day) and require higher operating costs in terms of working volumes and continuous 478 
addition of substances mimicking the gastrointestinal fluids. 479 
 480 
Static models 481 
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The simulation of the digestive process can be divided into 2 major stages: 482 
simulating gastric and small intestinal digestions, with conditions generally based on the 483 
method described by Miller and others (1981). Adaptations to this model have been 484 
made to modify the conditions and the procedures for studies of digestibility and 485 
bioaccessibility of phytochemicals, but the “physiological conditions” chosen vary 486 
considerably across different static in vitro studies. 487 
The comparative simplicity of static methods have allowed their adaptation to 488 
measuring the bioaccessibility of many phytochemicals from various fruits and 489 
vegetables, including phytosterols (Bohn 2008), glucosinolates (Iori and others 2004), 490 
carotenoids (Garret and others 1999; Failla and others 2008b) and many types of 491 
polyphenols (Gil-Izquierdo and others 2002). This simplicity allows the running of 492 
multiple samples in parallel. However, contrary to dynamic models, these static models 493 
typically fail to take into account dynamic physiological responses to the introduction of 494 
a food bolus, such as pH increase and following decrease in the stomach, and enzyme 495 
secretions in response to the food bolus introduced (Isenman and others 1999). 496 
However, adaptations of the static model have been carried out for the investigation 497 
of various phytochemicals, such as ultracentrifugation and/or filtration, to study the 498 
micellar phase of lipophilic constituents. While this is normally not done for polyphenol 499 
bioaccessibility, additional steps such as dialysis have occasionally been introduced 500 
(Bouayed and others 2012). 501 
 502 
Dynamic models 503 
Compared to static models, dynamic models have the advantage that they can 504 
simulate the continuous changes of the physicochemical conditions including  variation 505 
 
 
21
of pH from the mouth to the stomach and the intestine, altering enzyme secretion 506 
concentrations, and peristaltic forces in the gastrointestinal tract.  507 
Different dynamic gastric models have been developed and designed for detailed 508 
measurement of gastric biochemistry and mixing. Due to their closer resemblance to in 509 
vivo conditions, but much lower throughput, they are more suitable to further confirm 510 
results obtained in static models and to gain more detailed insights into changes 511 
occurring during digestion. The dynamic gastric model (DGM), developed at the 512 
Institute of Food Research (Norwich, UK), is composed of 2 successive compartments 513 
(Vardakou and others 2011). The model reproduces gastric emptying and secretion 514 
according to data derived from echo-planar magnetic resonance Imaging (EPI) and the 515 
rates of GI digestion obtained from human studies (Golding and Wooster 2010). The 516 
system was originally constructed to assess the impact of the first stages of digestion on 517 
the bioaccessibility and delivery profiles of nutrients to the duodenum. It simulates the 518 
physical mixing, transit, and breakdown forces (including flow, shear, and hydration), 519 
pH gradients, and gastric secretions.  520 
The human gastric simulator (HGS), a model developed at the University of 521 
California-Davis is composed of a latex chamber surrounded by a mechanical driving 522 
system to effectively simulate the frequency and intensity of the peristaltic movements 523 
in the stomach (Kong and Singh 2010). HGS is designed to mimic the gastric shear 524 
forces and stomach grinding. This appears to be important for bioaccessibility studies as 525 
the rate of release of phytochemicals, from fibrous particles, into the surrounding 526 
intestinal fluid is inversely proportional to particle size, and is directly proportional to 527 
phytochemical gradient. It is furthermore affected by the physical state of the 528 
phytochemical, the physical structure, and the surface properties of the particle 529 
(Palafox-Carlos and others 2011). To allow a closer simulation of in vivo physiological 530 
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processes occurring within the lumen of the stomach and small intestine,  some of the 531 
main parameters of digestion such as peristaltic mixing and transit, secretions, and pH 532 
changes, have been applied in some models. The TNO gastrointestinal model (TIM-1) 533 
developed by TNO in Zeist (The Netherlands), has been used for a broad range of 534 
studies (Minekus 1995). The system consists of 4 different compartments, representing 535 
the stomach, duodenal- jejunal and ileal parts of the gastrointestinal tract. Each 536 
compartment is composed of 2 glass jackets lined with flexible walls. The TIM-1 537 
system enables simulation of gastric emptying rate, peristaltic movements, and transit 538 
time through the small intestine and gradual pH changes in the different compartments 539 
(Minekus 1995), and has given useful information on the parameters affecting the 540 
release and digestive stability of carotenoids from different food matrices through the 541 
gastrointestinal tract (Minekus 1995; Blanquet-Diot and others 2009). This model has 542 
also been extensively used to assess both folate and folic acid bioaccessibility from 543 
foods (Öhrvik 2008; Öhrvik and others 2010).  544 
For polyphenols, there is not enough evidence as to which method is the most 545 
appropriate for measuring bioaccessibility, especially as it has become clear that the 546 
colon is greatly involved in the metabolism and absorption of these compounds (Bolca 547 
and others 2012; Czank C and others 2013; Ludwig IA and others 2013). Thus both 548 
static and dynamic models, those that do not take into account the simulation of the 549 
colon, will have limitations in predicting the bioavailability of polyphenols. However, 550 
with the development of additional models aiming to simulate colonic fermentation, 551 
such as the TIM-2 model, the non bioaccessible fraction following gastric and small 552 
intestinal digestion may be studied, such as was done for phenolic compounds in wheat 553 
bread (Mateo Anson and others 2009). 554 
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 An adapted model of TIM-1, a computer-controlled gastrointestinal model called 555 
Tiny-TIM, has more recently been used to assess the bioaccessibility of phenolic acids 556 
in breads (Hemery and others 2010). The model is a simplified and downscaled TIM-1 557 
for rapid screening. The main characteristics of the system are the same as for TIM-1, 558 
but instead of four compartments, the Tiny-TIM model consists of 2 compartments that 559 
represent the stomach and the small intestine. The results were found to be consistent 560 
both with the data from a previous study evaluating the bioaccessibility of phenolic 561 
acids in TIM-1 (Kern and others 2003) and a human study (Mateo Anson and others 562 
2009). To our knowledge, except for the comparison between the results obtained in the 563 
TIM-1 and Tiny-Tim model, so far no comparisons between the different dynamic 564 
models have been made. 565 
 566 
Setting up the model 567 
 568 
Digestion simulation of the oral cavity 569 
The oral cavity is the portal of entry of nutrients. Due to its unique constituents it 570 
may also be considered a “bioreactor” (Gorelik and others 2008; Mathes and others 571 
2010; Ginsburg and others 2012). Whole saliva is a very dilute fluid composed of more 572 
than 99% water. It contains a variety of minerals, various proteins (the major being the 573 
mucin glycoproteins, albumin, and digestive enzymes), and nitrogenous compounds as 574 
urea and ammonia (Ginsburg and others2012). An intensive mixing of simulated saliva 575 
and the introduced food bolus is usually desired, usually  in a ratio of 1:1, keeping in 576 
mind practicality and the basal flow of saliva during ingestion estimated at 1-3 mL/min 577 
(Engelen and others 2003). An ingested food or beverage undergoes a number of 578 
chemical, biochemical, and mechanical processes in the mouth, although not so 579 
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significant for liquids due to short residence time. There may occur changes in pH, ionic 580 
strength, and temperature, action of various digestive enzymes (notably lingual lipase, 581 
amylase, protease); interactions with biopolymers in the saliva (mucin); interactions 582 
with sensory receptors of the tongue and mouth; and particle size reduction of bolus by 583 
chewing (mastication). These are all major factors to take into consideration when 584 
designing an in vitro digestion step that simulates the human mouth (McClements and 585 
Li 2010). 586 
  587 
Particle size reduction 588 
A few studies have paid attention to how mechanical breakdown during the oral 589 
phase affects phytochemical bioaccessibility. Mastication consists of grinding food into 590 
smaller pieces and impregnating these pieces with saliva to form a bolus that can be 591 
swallowed. Decreasing the particle size enlarges the surface area available for hydration 592 
and action by digestive enzymes, thus increasing the overall digestion efficiency and 593 
gastrointestinal absorption of phytochemicals (Kulp and others 2003). A partial and 594 
short mastication might affect the availability of major phytochemicals from vegetables, 595 
fruits. However the inter-individual variability in the particle size of food boluses at the 596 
end of chewing is considered to be insignificant for overall bioaccessibility (Woda and 597 
others 2010), and the use of one individual to chew the meal and expectorate it prior to 598 
swallowing was found to be acceptable (Ballance and others 2012). However, more 599 
studies are needed to confirm that one subject is sufficient for investigating the effect of 600 
mechanical breakdown on phytochemical bioaccessibility during the oral phase.When 601 
studying bioaccessibility of carotenoids, techniques such as grinding or homogenizing, 602 
with a stomacher laboratory blender for different intervals in the presence of artificial 603 
saliva, were compared with physically masticated foods by humans (Lemmens and 604 
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others 2010). The average particle size distribution after human chewing was 605 
investigated and this information was used to simulate average mastication in vitro by a 606 
blending technique.  607 
To produce food boluses with properties similar to those resulting after natural 608 
chewing, the Artificial Masticatory Advanced machine (AM2) has been developed and 609 
validated against human subjects chewing raw carrots (cylindrical samples heigh 1 cm, 610 
diameter 2 cm, 4 g) and peanuts (3.5 g) (Mishellany-Dutour and others 2011). It was 611 
concluded that AM2 produces a food bolus with similar granulometric characteristics to 612 
human chewing, although no bioaccessibility parameters for phytochemicals were 613 
evaluated. 614 
 615 
Chemical and biochemical processes 616 
Due to the usually very short interaction of oral enzymes with the food bolus prior to 617 
reaching the stomach, their influence is much less clear and rather limited to 618 
carbohydrate-rich foods such as cereal-based foods (Hur and others 2011). For example, 619 
it is estimated that nearly 5% of the consumed starch is already degraded in the mouth 620 
cavity by salivary amylase (Hall 1996). Usually, in vitro methods are initiated using α-621 
amylase at pH around 7 (Table 1). 622 
Ginsburg and others (2012) suggested that saliva has an important role in the 623 
solubilization of polyphenols present in fruits and plant beverages and thus substantially 624 
increases their availability. Moreover, saliva can increase the stickiness to oral surfaces 625 
of polyphenols and their prolonged retention in the oral cavity and thus it contributes to 626 
the enhancement of the redox status of the oral cavity. Salivary albumin, mucins, and 627 
proline-rich proteins may be of particular importance affecting the digestibility and 628 
absorption of specific polyphenols, for example, tannins may be precipitated and 629 
 
 
26
retained by such proteins (Bennick 2002) through hydrogen bonding and hydrophobic 630 
interactions. 631 
In summary, an oral digestion phase may be recommended for carbohydrate-rich 632 
foods. Alternatively, starting with particles of small size (50-1,000 µm) may be 633 
appropriate, as this mimics the particle size following the chewing process for 634 
vegetables and fruits (Hoebler and others 2000; Lemmens and others 2010,). If oral 635 
digestion is left out, dry samples may be introduced at a ratio of approximately 1:4 636 
(food:liquid),  considering common meal sizes of approximately 200-300 g and a gastric 637 
juice volume of about 1L (Sergent and others 2009). A fluid of physiological salt 638 
concentration (saline) should be employed.   639 
 640 
The gastric phase of digestion  641 
The knowledge of disintegration of food inside the stomach is crucial for assessing 642 
the bioaccessibility of phytochemicals for both static and dynamic methods. Food 643 
disintegration in the stomach is a complex process including mechanical actions and 644 
activity of gastric fluids.  645 
 Gastric juice contains hydrochloric acid (HCl), pepsinogens, lipase, mucus, 646 
electrolytes and water. The rate of secretion varies from approximately. 1-4 mL/min 647 
under fasting conditions to between 1 and 10 mL/min after food intake (Wisen and 648 
Johansson 1992; Brunner and others 1995). The presence of HCl contributes to the 649 
denaturation of proteins and it activates pepsin.  650 
     Peristaltic waves originating from the stomach participate to the size reduction of 651 
solid foods down to a diameter of 1 to 2 mm (Kong and Singh 2010). Stomach 652 
emptying is a critical step in the digestion process. Several factors may influence the 653 
gastric emptying of food and fluids including volume, viscosity, and pH. The speed of 654 
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the emptying of liquid meals is directly proportional to the volume present in the 655 
stomach. Solid foods are emptied more slowly, in a biphasic pattern with a lag phase 656 
during which little emptying occurs, followed by a linear emptying. The duration 657 
depends on the physical properties and approximately 3 to 4 h are needed for a complete 658 
emptying of the stomach (Schulze 2006).  659 
A nutrient-driven feedback regulation from the small intestine, limiting the gastric 660 
emptying to a maximum of about 3 kcal/min has been suggested (Lin and others 2005, 661 
Kwiatek and others 2009) when other data point to a nutrient-dependent emptying 662 
pattern with emulsion fat emptying faster than glucose and protein (Goetze and others 663 
2007). Furthermore, the presence of dietary fibers is known to slow down gastric 664 
emptying of complex meals (Marciani and others 2001). 665 
 666 
pH 667 
The gastric pH in the fasted state in healthy human subjects is in the range of 1.3 to 668 
2.5. The intake of a meal generally increases the pH to above 4.5 depending on the 669 
buffering capacity of the food. For example, in nasogastrically intubated humans fed a 670 
western-type diet enriched in either tomato, or spinach or carrot purees, the stomach pH 671 
sharply increased to 5.4–6.2 after meal intake, then continuously decreased to reach 672 
1.8–2.9 after 3 h of digestion (Tyssandier and others 2003). Similarly, after ingestion of 673 
a cocoa beverage, the gastric pH reached 5.4 within 3 min before returning to the 674 
baseline pH of 1.9 (Rios and others 2002). Most static in vitro studies have been 675 
conducted at a pH below 2.5, which are conditions related to the human fasting state 676 
rather than to real food digestion. Only a few authors have considered as relevant a pH 677 
of 4 associated with the mid-step of digestion (Reboul and others 2006; Dhuique-Mayer 678 
and others 2007). The decay of gastric pH is however taken into consideration in 679 
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dynamic models as shown for the digestion of tomato carotenoids in the TIM system 680 
(pH 6 to 1.6) (Blanquet-Diot and others 2009). 681 
 682 
Enzymes 683 
Pepsin, which is readily available as porcine pepsin, has been integrated in most in 684 
vitro models of gastric digestion, although in varying amounts (Table 2). Pepsin content 685 
should be assessed as enzymatic activity per weight of protein for the sake of 686 
comparison. Gastric lipase is usually omitted. However, existence of lipolysis in the 687 
human stomach by gastric lipase is known (Carriere and others 1993; Armand and 688 
others 1994). Most of the dietary lipids are present in the form of emulsified droplets, in 689 
the range of 20-40 m, and it was suggested that gastric lipolysis can help to increase 690 
emulsification in the stomach (Armand and others 1994), which would thus enhance 691 
lipophilic phytochemical bioaccessibility. It was reported that human gastric lipase 692 
secretion ranged from 10 to 25 mg/3 h and that the percentage of intra-gastric lipolysis 693 
during gastric digestion was 5-40% (Carriere and others 1993: Armand 2007). Lipolysis 694 
catalyzed by gastric lipase has been found to primarily occur within the first hour of 695 
digestion (Armand and others 1994).  696 
Because human gastric lipase is unavailable, fungal lipases from Aspergillus niger or 697 
Aspergillus oryzae have been used, as in the TIM model. However, A. niger lipase has a 698 
wide pH optimum of 2.5-5.5 compared to 4.5 to 6 for human gastric lipase (Carriere et 699 
al., 1991). The fungal lipase can hydrolyze both the sn-1 and sn-3 positions of the 700 
triacylglycerol molecule, with a slight preference for the sn-1 position, whereas gastric 701 
lipase is most active at the sn-3 position (Van Aken and others 2011). Alternatively, a 702 
mammalian lipase such as rabbit gastric lipase could be used as Capolino and others 703 
(2011) demonstrated that its specificity is close to that of human lipase. At the present 704 
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time, a combination of rabbit gastric lipase and porcine pancreatic extract is favored to 705 
simulate in vitro gastrointestinal lipolysis. 706 
 707 
Oxygen, dietary iron and antioxidant activity of phytochemicals and 708 
micronutrients 709 
The presence of other food components may alter polyphenol and carotenoid stability 710 
in the gastric tract. After food intake, dietary iron, dioxygen, and emulsified lipids come 711 
into close contact and lipid oxidation may take place. This was demonstrated for heme 712 
(metmyoglobin) and nonheme iron (FeII/FeIII) forms in emulsion systems modeling the 713 
physical state of triacylglycerols (Lorrain and others 2012). Dietary polyphenols such as 714 
rutin, (+)-catechin, and chlorogenic acid proved to be better inhibitors of the 715 
metmyoglobin-initiated lipid oxidation than α-tocopherol and vitamin C (Lorrain and 716 
others 2010).  The antioxidant activity of polyphenols depended on an emulsifying 717 
agent (proteins, phospholipids) and pH. In this process, polyphenols were however 718 
consumed, giving rise to oxidation products which themselves retain antioxidant 719 
properties (Lorrain and others 2010). In this in vitro model of gastric digestion, 720 
lycopene and ß-carotene proved to be less efficient inhibitors of lipid oxidation 721 
compared to bacterial carotenoids (mainly glycosylated apolycopenoids) (Sy and others 722 
2012b). Phenolic compounds and carotenoids had complementary mechanisms of 723 
action: the former inhibited the initiation step of lipid peroxidation by reducing the 724 
prooxidative FeIII species of myoglobin when the latter inhibited the propagation phase 725 
by direct scavenging of the lipid peroxyl radicals. Oxygen may thus impact 726 
phytochemical and micronutrient stability in the gastric tract. The level of dissolved O2 727 
increases during mastication of food (Gorelik and others 2005), whereas the presence of 728 
a marked oxygen partial pressure gradient from the proximal to the distal GI tract was 729 
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evidenced in living mice from 58 torr in the mid-stomach, 32 torr in the mid-duodenum, 730 
11 torr in the mid-small intestine and mid-colon to 3 torr in the distal sigmoid colon-731 
rectal junction (compared to 160 torr for O2 in air) (He and others 1999). For this 732 
reason, some authors suggested flushing with nitrogen or argon for a few minutes to 733 
reduce the levels of dissolved O2 (Bermudez-Soto and others 2007).   734 
 735 
Static models 736 
Static modeling of gastric digestion of phytochemicals is basically conducted by a 737 
pepsin hydrolysis of homogenized food under fixed pH and temperature for a period of 738 
time. The internal body temperature (37 °C) is classically used. Dynamic processes 739 
occurring during human digestion such as mechanical forces or continuous changes in 740 
pH and secretion flow rates are usually not reproduced (Guerra and others 2012). There 741 
are many studies on in vitro digestion of phytochemicals using static models, and they 742 
only differ slightly (Table 2). The major differences among the methods used for 743 
modeling gastric phase digestion are (i) addition or absence of phospholipid vesicles; 744 
(ii) addition or absence of lipase; (iii) incubation time between 0.5 h to 2 h; (iv) pH 745 
varying from 1.7 to 2.5;  and (v)  pepsin to substrate ratio. 746 
For highly processed plant matrices, it appears that the large majority of polyphenols 747 
is already released in the gastric phase. Indeed, the polyphenol bioaccessibility from 748 
fruit juices, wines, green tea, or phenolic extracts, in the presence of simulated gastric 749 
juices (pH 1.7-2.5, pepsin, 1-4 h) is nearly 100% (Perez-Vicente and others 2002; 750 
McDougall and others 2005a; McDougall and others 2005b; Bermudez-Soto and others 751 
2007; Greenand others 2007; McDougall and others 2007; Gumienna and others 2011) 752 
but can be only between 30-100% from solid matrices such as homogenized peaches, 753 
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apple, grape berries, cherries or carob flour (Fazzari and others 2008; Bouayed and 754 
others 2011; Ortega and others 2011; Tagliazucchi and others 2012).  755 
Among phenolic compounds, apple flavanols (epicatechin and procyanidin B2), as 756 
well as chokeberry proanthocyanidin oligomers, were more degraded than 757 
caffeoylquinic derivatives, flavonols, or anthocyanins. Cocoa proanthocyanidins 758 
(trimers to hexamers) and apple procyanidin B2 were shown to undergo 759 
depolymerization in a simulated gastric juice (37 °C, pH 1.8-2.0) (Spencer and others 760 
2000, Kahle and others 2011), whereas in vivo, this degradation was not validated, 761 
mainly because the stomach pH increased to 5.4 after the ingestion of the cocoa 762 
beverage and progressively decreased to the basal value as the stomach emptied (Rios 763 
and others 2002).  764 
Certain epoxycarotenoids, such as violaxanthin and neoxanthin from spinach, were 765 
shown to undergo epoxide-furanoid transitions at pH 2 (Biehler and others 2011a). This 766 
transformation extent may clearly depend on the gastric acidity and time of exposure.   767 
 768 
Dynamic models 769 
Dynamic gastric models of digestion incorporate i) mixing of the non homogeneous 770 
gastric digesta which is best modeled by peristaltic movements as in the HGS model 771 
(Kong and Singh 2010), ii) acidification, iii) addition of gastric enzymes, and iv) 772 
delivery to the duodenum (Chen and others 2011). Usually, computer-controlled 773 
protocols are designed to deliver secretions and chime (digesta) in the normal 774 
physiologic range. Dynamic models are described in more details in the previous 775 
section “Digestion models for studying phytochemical bioaccessibillity”. Up to now, 776 
few applications have been reported for phytochemicals compared to the numerous data 777 
in static models. For example, in the TIM-1 system, tomato (E)-beta-carotene and (E)-778 
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lycopene proved to be stable, although the recovery yield was modulated by the tomato 779 
matrix (Blanquet-Diot and others 2009). The Tiny TIM-1 system was used to evaluate 780 
the bioaccessibility of phenolic acids in breads made from processed wheat bran 781 
fractions (Hemery and others 2010). The amount of bioaccessible phenolic acids was 782 
enhanced by using finer particles in  bran-rich breads.  783 
 784 
General considerations 785 
The rapid release of the phenolic compounds in the stomach maximizes the potential 786 
for absorption in the small intestine. For lipophilic compounds, such as for carotenoids, 787 
such comparisons would not appear meaningful, as the formation and incorporation of 788 
the mixed micelles are mostly achieved during the small intestinal stage.  789 
Several major aspects deserve consideration during the gastric digestion, including 790 
the limitation of oxygen, either by flushing with inert gasses or by reducing the 791 
headspace volume to a minimum, the inclusion of gastric lipase, especially for lipid-792 
soluble compounds, and a sufficient protein degradation capacity to allow release of 793 
phytochemicals. An initial low pH (<3) is not physiological and should be avoided due 794 
to non optimal functioning of enzymes, especially of lipase.  795 
 796 
 Digestion in the small intestine 797 
After food disintegration in the mouth and stomach, the main enzymatic digestion 798 
and absorption of nutrients take place in the small intestine. After stomach digestion, the 799 
acidic chyme is delivered to the small intestine and neutralized with sodium bicarbonate 800 
to give an appropriate pH for enzyme activities.  801 
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The in vitro small intestinal digestion of phytochemicals is generally applied by 802 
mimicking pH, temperature, time, and pancreatic juice including electrolytes, bile salts, 803 
and enzymes. 804 
 805 
pH, enzymes and bile salts 806 
In the fed state, pH can vary from 5.4-7.5 in the duodenum (Tyssandier and others 807 
2003; Kalantzi and others 2006; Clarysse and others 2009), to 5.3-8.1 in the jejunum 808 
(Lindahl and others 1997; Perez de la Cruz Moreno and others 2006), and up to 7.0-7.5 809 
in the ileum (Daugherty and Mrsny 1999) (Table 3).  810 
Pancreatic enzymes including proteases, amylases, and lipases, as well as other 811 
digestive enzymes (brush border enzymes, like maltase, lactase,-dextrinase, 812 
peptidases) produced by the brush border, a microvillus membrane at the luminal 813 
surface of the small intestine (Holmes and Lobley, 1989), all act together on the 814 
breakdown of food constituents.  815 
In vivo bile salt concentrations were found to be higher in the fed state (3-12 mM 816 
range) than in the fasted state and variable between duodenum and jejunum (Table 3). 817 
The major differences among the methods are the forms of enzymes (pancreatin or 818 
individual enzymes) and biliary acids used (bile salt mixtures, real fresh bile, or 819 
individual bile salts) (Table 3). Very few models use individually prepared bile salts and 820 
enzymes (including porcine pancreatic lipase, porcine colipase, porcine trypsin, bovine 821 
chymotrypsin, and porcine amylase), although this may give better control over 822 
enzymatic activity (Mandalari and others 2010). Several studies have reported that the 823 
presence of bile salts and pancreatic enzymes is essential for the efficient 824 
micellarization of lipophilic compounds (Garrett and others 1999; Hedrén and others, 825 
2002, Wright and others 2008; Biehler and others, 2011a).  In the study by Biehler and 826 
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others (2011a), carotenoid micellarization from spinach was strongly reduced in the 827 
absence of pancreatin and bile salts, while it was not significantly impacted by the 828 
omission of pepsin during gastric digestion (Biehler and others2011a). Minimal bile salt 829 
concentration of 2.4 mg/mL (about 5 mM), within the in vivo concentration range, was 830 
required for optimal transfer of lutein and beta-carotene from lipid droplets into mixed 831 
micelles (Garrett and others 1999, Wang and others 2012). It was also shown that the 832 
maximum beta-carotene transfer was obtained at pH 6, in relation to the activity of 833 
pancreatic lipase, which is most efficient at this pH, and with a pancreatic lipase 834 
concentration of 0.4 mg/mL (Wang and others 2012). At higher bile salt concentration, 835 
beta-carotene micellarization could depend on the activity of pancreatic colipase-836 
dependent lipase (Wright and others 2008). As to polyphenols, the hydrophilic forms 837 
such as glycosylated flavonols or quinic acid derivatives of hydroxycinnamic acids may 838 
readily solubilize in the aqueous phase when less soluble flavonoid aglycones or 839 
procyanidins will bind to dietary fibers and proteins for transport. A bile salt-dependent 840 
micellarization has however been suggested for isoflavone aglycones (Walsh, Zhang, 841 
Vodovotz, Schwartz and Failla 2003).   In the intestinal conditions, the bioaccessibility 842 
and stability of polyphenols depends mainly on pH. In near neutral conditions and in the 843 
presence of oxygen as it occurs in most in vitro models, some phenolic compounds may 844 
be degraded through non enzymatic oxidation (Bergmann and others 2009). 845 
Examination of the recovery of specific classes revealed that flavan-3-ols were poorly 846 
recovered following the digestion of a grape-orange-apricot juice (Cilla and others 847 
2009) but not in chokeberry juice (Bermudez-Soto and others 2007). Pure (+)-catechin 848 
was recovered at only 42% after incubation with pancreatin (Bermudez-Soto and others 849 
2007), while (-)-epicatechin and procyanidin B2 from homogenized apple were not 850 
recovered after the intestinal step (Bouayed and others 2012). The high affinity of 851 
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monomeric and oligomeric flavanols for proteins and dietary fibers may also lead to 852 
their loss during the solid removal step by centrifugation (Le Bourvellec and Renard 853 
2011). For green tea flavanols, the stability order was epicatechin > epicatechin gallate 854 
> epigallocatechin = epigallocatechin gallate, in agreement with the higher oxidizability 855 
of the 1,2,3-trihydroxyphenyl moiety compared to the 1,2-dihydroxyphenyl one (Green 856 
and others 2007). The recovery of caffeoylquinic acids appears to be more affected by 857 
the intestinal step than by the gastric step as observed for apple, a grape-orange-apricot 858 
beverage, and red wine (Cilla and others 2009; Gumienna and others 2011; Bouayed 859 
and others 2012, ). Chlorogenic acid (5-caffeoylquinic acid) may autooxidize, although 860 
regio-isomerization is a major pathway as described for p-coumaroyl- and 861 
caffeoylquinic acids by Kahle and others 2011. Anthocyanins appear to be the most 862 
sensitive class and may largely disappear in the intestinal step (McDougall and others 863 
2005a, b, 2007; Bermudez-Soto and others 2007; Tagliazucchi and others 2010, 2012). 864 
The quantification of anthocyanins is complicated by a pH-dependent equilibrium of the 865 
red flavylium cation to several related structures at pH above 2. The hydration of the 866 
flavylium cation produces a colorless hemiketal which is in equilibrium with colorless 867 
(E)- and (Z)-chalcone forms. In the near-neutral conditions of intestinal digestion, a first 868 
deprotonation of the flavylium cation provides neutral quinonoidal bases (pKa ≈ 4) 869 
which can further be deprotonated to ionic quinonoidal bases (pKa ≈ 6), both bases 870 
displaying blue and violet hues (Brouillard and others 1991; Clifford 2000). Thus, the 871 
detection of anthocyanins in simulated gastrointestinal conditions can be challenging as 872 
it is influenced by pH and copigment molecules. For example, Perez-Vicente and others 873 
(2012) evaluated the recovery of pomegranate anthocyanins to be 18% when measured 874 
at the pH of the intestinal digesta and 70% following acidification of the digesta at pH 875 
2. Analysis of anthocyanins at pH lower than 2 should be favored as it is more 876 
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convenient to evaluate the flavylium cation form by high-performance liquid 877 
chromatography (HPLC) or colorimetric tests.  878 
When exposed to acids or bases, ester bonds in ellagitannins and caffeoylquinic acids 879 
are hydrolyzed and the hexahydroxydiphenic acid is spontaneously rearranged into the 880 
water-insoluble ellagic acid (Clifford and Scalbert 2000). Daniel and others (1991) 881 
showed that ellagic acid could be released from raspberry ellagitannins at pH 7 and 882 
optimally at pH 8. Furthermore, Gil-Izquierdo and others (2002) observed a 5-to 10-fold 883 
increase in ellagic acid from strawberry ellagitannins during incubation with pancreatic 884 
enzymes in mild alkaline conditions (Gil-Izquierdo and others). This may be the 885 
mechanism behind the relative increases in smaller ellagitannin molecules noted during 886 
in vitro digestion of raspberry and strawberry extacts (McDougall and others 2007; 887 
Brown and others 2012,). In the mildly alkaline conditions of in vitro digestion, orange 888 
flavanones form less soluble chalcone forms which precipitate (Gil-Izquierdo and others 889 
2003). However, more than 90% of orange flavanones and 80% of soy isoflavone 890 
glycosides were recovered after the intestinal step outlining their high stability toward 891 
autoxidation (Walsh, Zhang, Vodovotz, Schwartz and Failla 2003, Gil-Izquierdo, Gil, 892 
Tomas-Barberan and Ferreres 2003).The sensitivity to autoxidation is probably 893 
overestimated in in vitro digestion models as oxygen is known to largely disappear in 894 
the gastric tract. Last, it should be noted that proteolytic enzymes could play a role in 895 
polyphenol bioaccessibility by releasing phenolic compounds bound to dietary proteins 896 
as observed in the gastric tract for pepsin. However, more data support a role for 897 
phenolic compounds as inhibitors of intestinal enzymes such as trypsin and lipase 898 
(Gonçalves and others, 2007; He and others, 2006).  899 
 900 
 901 
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Static models 902 
Conditions used in in vitro static models simulate quite well the physiology of 903 
intestinal digestion with the use of porcine pancreatin, biliary extract or bile salts, and a 904 
pH ranging between 6.0 and 7.5 (Table 3).  However, the time allowed for this step is 905 
highly variable (0.5-2.5 h). A too short digestion time may lead to trapping of 906 
carotenoids in triglycerides, and thus underestimation of carotenoid bioaccessibility (Sy 907 
and others 2012a). Different carotenoids show differing micellarization. Xanthophylls 908 
(lutein and beta-cryptoxanthin) showed higher micellarization compared to alpha- and 909 
beta-carotenes, while lycopene was only slightly micellarized (Garrett and others 2000; 910 
Reboul and others 2006; Thakkar and Failla 2008). There have also been differences 911 
noted between (E)-carotenoids and their (Z)-isomers (Chitchumroonchokchai and others 912 
2004; Bengtsson and others 2010; Biehler and others 2011b), with the latter commonly 913 
found in processed foods, also tending to be better micellarized (Bohn 2008). It could 914 
also be speculated that a prolonged time of small intestinal digestion will favor the 915 
formation of more Z-isomers. However, the in vivo data showed no significant 916 
isomerization either in the stomach or in the duodenum for beta-carotene and lycopene 917 
(Tyssandier and others 2003).  918 
In most in vitro studies, the stability of phenolic compounds has been assessed by 919 
determining total phenolic content such as the Folin-Ciocalteu method (Singleton L and 920 
Rossi 1965), which does not yield information on the reactivity of specific phenolic 921 
classes or molecules. The intestinal step, when compared to the gastric step, did not 922 
influence the recovery of total phenolic compounds for homogenized prunes (81% of 923 
the initial conc. in fruit) (Tagliazucchi and others 2012), grape berries (62%) 924 
(Tagliazucchi and others 2010), cherries (127%) (Fazzari and others 2008), 925 
pomegranate juice (100%) (Perez-Vicente and others 2002) and red cabbage extract 926 
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(100%) (McDougall and others 2007). However, a loss in total phenolics during the 927 
intestinal step was observed for plums (44%), peaches (37%), tomato (31%) 928 
(Tagliazucchi and others 2012), chokeberry juice (73%) (Bermudez-Soto and others 929 
2007), raspberry extract (86%) (McDougall and others 2005b), and red wine (47% and 930 
58%) (Gumienna and others 2005b), many of which contain labile anthocyanins.  In 931 
conclusion, the analysis of specific phenolic compounds should be addressed in order to 932 
avoid conflicting results. Additionally, findings on the recovery of different classes in 933 
one fruit/vegetable cannot be readily extended to other sources as stability in vitro is 934 
influenced by interactions with the other phenolic compounds in the mixture and 935 
vitamin C (for example sacrificial oxidation). 936 
 937 
Dynamic models 938 
To simulate the in vivo conditions of the small intestine, dynamic models can be used 939 
to reproduce pH changes and secretion of pancreatic juice and bile. In the TIM model, 940 
the intestinal transit time and pH conditions in the human digestive tract are simulated 941 
through pre-programmed pH and delivery curves (Minekus 1995). Porcine pancreatin, 942 
bile salts, electrolytes, and NaHCO3 are secreted by computer-controlled pumps.  The 943 
model does not mimic brush border secretions. pH usually increases between the 944 
duodenal, jejunal, and ileal compartments, for example, from 6.4 to 7.2 for the digestion 945 
of a tomato-containing Western diet (Blanquet-Diot and others  2009). The 946 
gastrointestinal transit time may greatly influence the bioaccessibility of phytochemicals 947 
by affecting the release from the food matrix. Additionally, the solubility and stability 948 
of different compounds may be affected by the time they are exposed to the conditions 949 
in the intestinal tract.  Apart from the integration of key parameters of digestion as 950 
peristaltic mixing, transit time, and transport, the ability to remove digested material by 951 
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passive absorption of water and digested molecules through a dialysis system is also an 952 
important feature of in vitro models. In particular, removal of digested molecules should 953 
prevent product inhibition of the pancreatic enzymes (Minekus 1995).  954 
The TIM-1 and Tiny-TIM systems have shown their usefulness in studying the 955 
digestive stability of carotenoids from tomato, and phenolic acids present in bread, 956 
respectively (Blanquet-Diot and others 2009, Hemery and others 2010). The TIM-1 957 
system can be equipped with semi-permable hollow fiber membrane filters (with a 958 
molecular weight cut-of ranging between 3-5 kDa to 5-8 kDa, depending on filter type) 959 
connected to the jejunal and ileal compartments in order to remove degraded 960 
compounds and to simulate absorption of water soluble nutrients. For the estimation of 961 
the bioaccessibility of lipophilic carotenoids, the incorporation into micelles is crucial 962 
and for this purpose the TIM system needs to be equipped with a specific membrane 963 
that separates the micellar phase from the fat phase (Minekus 1995). The formation of 964 
micelles which are less than 10 nm in size is dependent, among other factors, on the 965 
presence of fat and bile salts, and the digestion protocol should be adequately designed 966 
to ensure triglyceride hydrolysis and micellarization by bile salts.   967 
 968 
General considerations 969 
The contribution of the intestinal step to the bioaccessibility of phenolic compounds 970 
is clearly influenced by several parameters. First, the action of intestinal enzymes on the 971 
residual matrix could increase the phenolic content. Next, phenolic compounds are 972 
chemically reactive in near-neutral conditions and their degradation or isomerization 973 
may be catalyzed by the presence of oxygen and/or transition-metal ions. Additionally, 974 
specific absorption by the small intestine can occur by passive diffusion or active 975 
transport, as demonstrated for aglycones and their glucosylated forms. The latter forms 976 
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can be actively transported by the sodium-glucose-linked transporter 1 (SGLT1) found 977 
in the enterocytes. Extracellular hydrolysis can be promoted by lactase phlorizin 978 
hydrolase (LPH) in the brush border and be followed by diffusion of the resulting 979 
aglycone into the enterocyte (Day and others 2000).  A transcellular transport involving 980 
multidrug resistance protein and P-glycoprotein transporters appears to be favored for 981 
hydroxycinnamic acid and flavonol aglycones (Poquet and Clifford 2008, Barrington 982 
and others 2009). These 2 phenomena cannot be readily modeled in vitro. Therefore, in 983 
vitro digestion methods may over estimate the levels of these phenolic components. In 984 
summary, a further limitation in oxygen, an inclusion of brush border enzymes or 985 
analogs with -glucosidase activity, a sufficient bile salt concentration, and the presence 986 
of lipolytic, amylolytic and proteolytic enzymes for specific nutrient digestion are all of 987 
importance for an optimal release of phytochemicals. While remaining triglycerides 988 
may trap lipid-soluble phytochemicals, incompletely digested proteins and 989 
polysaccharides will bind to water-soluble phytochemicals, making them unavailable in 990 
the small intestine.  991 
 992 
Large intestinal bioconversions   993 
The colon contains a highly complex microbial ecosystem, which is capable of 994 
fermenting food components not digested in the upper GI tract. Some undigested food 995 
ingredients, including certain polyphenols, can act as substrate for the indigenous 996 
bacterial community (Possemiers and others 2011). In addition, microbial bioconversion 997 
products can influence the overall intestinal ecosystem and the bioavailability of the 998 
parent compounds. Carotenoids are typically not studied in colonic models, as they are 999 
primarily absorbed in the small intestine, and colonic metabolites have not been 1000 
reported so far. Colonic bioconversion of polyphenols is most well-described for 1001 
 
 
41
flavonoids (Table 4) and phytoestrogens, lignans and isoflavonoids. The complexity of 1002 
in vitro colonic models used to study the metabolism of phenolic compounds is diverse, 1003 
ranging from batch fecal incubations using a strictly anaerobic and dense fecal 1004 
microbiota suitable for metabolic studies (Barry 1995; Gross and others 2010; Aura and 1005 
others 2012) to more complex continuous models involving one or multiple connected, 1006 
pH-controlled vessels representing different parts of the human colon (Fogliano and 1007 
others 2011) or in vitro dynamic gastrointestinal-colonic system models (Gao and others 1008 
2006; Van Dorsten and others 2012) , which are applicable also to study effects of food 1009 
components on the microbial population.  1010 
Characterization of phenolic metabolites using in vitro colonic models is 1011 
complementary to the metabolic bioconversion by the small intestine or the liver 1012 
(methylation, sulfation, and glucuronidation) of the native forms in which they are 1013 
present in foods (Scalbert and others 2002) and shows the diversity of structural 1014 
transformations occurring in the colon prior to absorption (Aura 2008; Selma and others 1015 
2009). Colonic metabolism of phenolic compounds starts with the transient appearance 1016 
of aglycones and the subsequent formation of hydroxylated aromatic compounds and 1017 
phenolic acids (Rechner and others 2004; Aura 2008). . Flavones, flavanones, flavanols, 1018 
proanthocyanidins, and phenolic acids share hydroxyphenylpropionic acid metabolites 1019 
(Rechner and others 2004; Aura 2008), whereas flavonols (quercetin, myricetin) and 1020 
ferulic acid dimers share hydroxylated phenylacetic acid metabolites (Aura and others 1021 
2002, Braune and others 2009). Moreover, flavanols also yield hydroxyphenylvaleric 1022 
acids and corresponding valerolactone derivatives (Aura and others 2008; Sanchez-1023 
Patan and others 2012). Anthocyanins yield benzoic acids, hydroxylated benzaldehydes, 1024 
and acetaldehydes (Aura and others 2005; Fleschhut and others 2006; Czank and others 1025 
2013). Complex microbial metabolites, such as lactones formed from plant lignans or 1026 
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ellagitannins (Heinonen and others 2001; Cerda and others 2004), are re-absorbed from 1027 
the colon and are subject again to liver metabolism and the conjugate derivatives are 1028 
excreted via urine (Adlercreutz and others 1995). Thus plasma and urine excretions 1029 
reflect both the hepatic and colonic metabolism of polyphenols (Table 4). 1030 
Limitations of in vitro colonic models include that they may not fully represent the 1031 
microbiota present in the colonic lumen and mucosa and that the combined rates of 1032 
catabolism and absorption that occur in vivo are not reproduced. However, the use of 1033 
colonic models provides information on the types of microbial metabolites formed 1034 
(Table 4) and helps to elucidate the pathways involved. Batch models are of particular 1035 
interest for a first assessment of colonic metabolism of phenolic compounds, which is 1036 
characterized by a high inter-individual variability (Gross and others 2010), or for 1037 
comparison of different sources or doses of compounds (Bolca and others 2009). The 1038 
anaerobic batch colonic model developed by Barry and others (1995), which uses 1039 
pooled human feces from several healthy donors, has been particularly suitable as 1040 
coupled with a metabolomics platform to investigate the effects of structure and dose of 1041 
fruit proanthocyanidin fractions on the efficiency of microbial metabolism and structure 1042 
of flavanol monomers (Aura and others 2012; Aura and others 2008).  1043 
Dynamic, multi-compartment colonic models are useful for long-term experiments 1044 
needed to evaluate the spatial and temporal adaptation of the colonic microbiota to 1045 
dietary phenolic compounds and the microbial metabolism of these phytochemicals. 1046 
These models are designed to and should harbor a reproducible microbial community 1047 
that should be stable upon inoculation, colon region-specific, and relevant to in vivo 1048 
conditions (Macfarlane and others 1998; Van den Abbeele and others 2010). Dynamic 1049 
colonic models have shown that microbial metabolism of black tea and red wine (Van 1050 
Dorsten and others 2012) and cocoa (Fogliano and others 2011) is dependent on colon 1051 
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location. In addition, dynamic models may be used to enrich the colonic microbiota 1052 
with polyphenol-converting species such as Eubacterium limosum to increase the 1053 
production of 8-prenylnaringenin from hop extracts (Possemiers and others 2008). 1054 
Dynamic colonic simulators have integrated new tools to improve modeling the 1055 
physiological colonic conditions, such as the incorporation of a mucosal environment 1056 
(Macfarlane and others 2005; Van den Abbeele and others 2012) and a mucus layer 1057 
combined with epithelial cells (Marzorati and others 2011). The models can 1058 
differentiate between the luminal microbiota with a large metabolic degradation 1059 
capacity and the mucosa-associated microbiota able to closely interact with the host.  1060 
An important element to be considered for designing colonic model experiments is 1061 
the use of one or multiple fecal donors in terms of diversity of the microbiota 1062 
population, as high-and low-polyphenol metabolizing phenotypes can skew the extent 1063 
of metabolism of certain compounds (Selma and others 2009; Bolca and others 2012). 1064 
Meanwhile, comparison of human gut metagenomes has suggested the classification of 1065 
individuals into three distinc enterotypes (Arumugan and others 2011). The 1066 
maintenance of anaerobic conditions during stool processing and inoculation to the 1067 
models is crucial for microbial and enzymatic activities. Another important matter to be 1068 
considered is the pH adjustment needed to avoid suppression of particularly minor 1069 
conversion activities, for example slow enterolactone formation (Aura 2008). In 1070 
summary, in vitro colonic models are the preferred choice to study mechanisms of 1071 
polyphenol microbial metabolism as well as the polyphenol-induced modulation of gut 1072 
microbiota. However, the ability of colonic models to simulate the in vivo conditions is 1073 
limited by the lack of studies involving the formation of microbial biofilms adhering to 1074 
the colonic epithelium. The simulation of intestinal absorption to remove end products 1075 
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of microbial metabolism is also relevant to prevent inhibition of the colonic microbiota 1076 
during in vitro studies.  1077 
 1078 
Determination of bioaccessible fraction and further coupling techniques following 1079 
digestion and/or colonic fermentation  1080 
 1081 
During the past few years in vitro digestion model systems have been used to analyze 1082 
the structural and chemical changes that occur in different foods under simulated 1083 
gastrointestinal conditions. These methods either simulate either disintegration, food 1084 
matrix and digestion processes only (for bioaccessibility) or both digestion and 1085 
absorption processes (for bioavailability estimates). According to the desired endpoints 1086 
of the studies, there are considerable differences in the type of experimental parameters 1087 
measured after digestion. These include chemical changes (such as hydrolysis of 1088 
macronutrients), gastric solubilization of drugs, nutrient availability, release of 1089 
encapsulated components, studying competitive processes, and structural changes (such 1090 
as break-down of specific structures), aggregation, droplet coalescence, or droplet 1091 
disruption (Chen and others 2011). Thus, samples obtained by in vitro digestion, either 1092 
following small intestinal digestion or following further colonic fermentation in vitro, 1093 
have been used in a variety of ways. In addition, the obtained fractions have been 1094 
coupled to further investigation prodcedures, allowing for example the estimation of 1095 
uptake into or transport through the intestinal epithelium. 1096 
  1097 
Estimation of bioaccessibility  1098 
The estimation of the bioaccessibility of non-polar food constituents such as 1099 
carotenoids has been made both by measuring the transfer of carotenoids from the food 1100 
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matrix to the aqueous layer obtained after in vitro digestion and centrifugation (Hedrén 1101 
and others 2002; Bengtsson and others 2009) or by filtering the aqueous fraction 1102 
through a 0.22 µm membrane to obtain micelles (Reboul and others 2006; Huo and 1103 
others 2007), or both. Since the micellarized carotenoids are considered to be the form 1104 
in which these compounds will ultimately be absorbed by the intestinal cells, it has been 1105 
suggested that assessment of carotenoid bioaccessibility must include the isolation, 1106 
extraction and measurement of carotenoids in micelles (Etcheverry and others 2012). 1107 
Reboul and others (2006) showed a high correlation (r= 0.90) of the in vitro 1108 
bioaccessibility of α- and -tocopherol, β-carotene, and lycopene with the in vivo values 1109 
measured in the micellar phase from human duodenum during digestion of a carotenoid-1110 
rich meal. Their findings suggest that estimation of carotenoid micellarization in vitro 1111 
can be indicative of the amount available for uptake in the gastrointestinal tract in vivo.  1112 
For polyphenols, Bouayed and others (2011, 2012) studied bioaccessibility following 1113 
simulated gastric and intestinal in vitro digestion of fresh apple. They used a cellulose 1114 
semi-permeable membrane, chosen as a simplified mechanical model for the epithelial 1115 
barrier to identify dialyzable polyphenols after intestinal digestion. They suggested that 1116 
dialyzable polyphenols in the intestinal phase could potentially be taken up by the 1117 
enterocytes and suggested it may be a practical step prior to coupling to cellular 1118 
methods due to increased purity of the dialysate, preventing negative impacts on cell 1119 
viability. Similar studies were performed by other researchers (Liang and others 2012, 1120 
Rodriguez-Roque and others 2013). At the same time, it is difficult to study the in vivo 1121 
changes and digestive stability of different food constituents during their passage 1122 
through the digestive tract, albeit some approaches, such as studying ileostomists, have 1123 
allowed some comparisons to in vitro small intestinal digestion (Walsh and others 2007; 1124 
Erk and others 2012). 1125 
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 1126 
Bioaccessibility following colonic fermentation 1127 
In vitro digestion procedures have also been employed to produce berry samples that 1128 
are characteristic of components that survive digestion, and therefore more 1129 
physiologically relevant, for studies on bioactivities relevant to colon cancer models 1130 
(Brown and others 2012).  1131 
Due to the limited sampling possibilities (and intra- and inter-individual variations), 1132 
the function and the composition of ileal microbiota is hard to study in vivo. The effect 1133 
of small intestinal microflora on the enzymatic hydrolysis of phenol glycosides was 1134 
studied in an ex vivo ileostomy model (Knaup and others 2007). Ileostomy effluents 1135 
from 3 healthy subjects were used for incubation with synthetic quercetin and p-1136 
nitrophenol glycosides. The conclusion was that the hydrolysis of phenol glycosides is 1137 
influenced both by the structural components of the phenols and the microflora in the 1138 
small intestine. Schantz, Erk and Richling (2010) have also reported evidence of 1139 
degradation of polyphenols in the small intestine, using an ex vivo ilostomy model to 1140 
study the microbial metabolism and chemical stability of green tea cathechins and gallic 1141 
acid.According to studies in ileostomy patients, the ileal microbiota is restored 6 months 1142 
after surgery (Hove and Mortensen, 1996) which may resemble the reflux situation 1143 
occurring in subjects with a healthy colon, or even take the role of colon fermentation to 1144 
some extent in ileostomy patients. 1145 
Phenolic microbial metabolites are relevant in terms of human health because they 1146 
appear in plasma and are excreted in urine (Aura 2008). Pharmacokinetic studies show 1147 
that microbial metabolite concentrations are elevated for up to 24-48 h in the 1148 
bloodstream after a single dose of their precursors before returning to baseline values 1149 
(Sawai and others 1987; Gross and others 1996; Kuijsten and others 2005). 1150 
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Enterolactone, enterodiol, and urolithins are excreted via urine as hepatic conjugates 1151 
(Heinonen and others 2001; Cerda and others 2004), whereas microbial phenolic acid 1152 
metabiltes appear in urine mainly in a free form in contrast to beverage- derived 1153 
phenolic acids which are excreted mainly as sulphates and glucoronides (Sawai and 1154 
others 1987; Stalmach and others 2009). In a recent work, Ludwig and others (2013) 1155 
show that after ingestion of coffee, the main colon-derived metabolites found in plasma 1156 
and/or in urine were dihydrocaffeic acid, dihydroferulic acid, and their sulfated and 1157 
glucuronidated metabolites. As the metabolites described above and their hepatic 1158 
conjugates are found in plasma and urine, therefore they circulate through the body and 1159 
may exhibit both local and systemic effects. Phenolic metabolite levels in plasma range 1160 
from low to high nano molar concentrations (Sawai and others Ando 1987; Kilkkinen 1161 
and others 2001; Kern and others 2003; Johnsen and others 2004; Kuijsten and others 1162 
2006), whereas urinary levels are at the micro molar range. In peripheral tissues, the 1163 
concentrations can be anticipated to be even lower.  1164 
A good example of studies including in vitro digestion models and colon conversion 1165 
and pharmacokinetic studies in human volunteers was performed by Mateo Anson and 1166 
others (2009, 2011). The group showed that bioprocessing of wheat bran with enzymes 1167 
(xylanase, cellulose, β-glucanase, and feruloyl esterase) and yeast enhanced the 1168 
bioaccessibility of ferulic acid, para-coumaric acid, and sinapic acid from white wheat 1169 
bread matrix in the in vitro gastrointestinal models TIM-1 and TIM-2 by 5-fold. Since 1170 
the release of para-coumaric acid and sinapic acid occurred mainly in the TIM-1 model 1171 
simulating the upper intestine, the microbial conversion products (3-(3'-hydroxyphenyl) 1172 
propionic acid and 3-phenylpropionic acid) from the TIM-2 colon model were shown to 1173 
be related to matrix bound ferulic acid content (Mateo Anson and others 2009). In a 1174 
subsequent pharmacokinetic in vivo study volunteers consumed 300 g white wheat 1175 
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bread samples fortified with either native or bioprocessed wheat bran, and then phenolic 1176 
acids and their metabolites were followed for 24 hours. The release and conversion of 1177 
microbial metabolites were enhanced by bioprocessing of bran by 2- to 3-fold and their 1178 
time course profiles in plasma were altered by bioprocessing of bran (Mateo Anson and 1179 
others 2011). 1180 
 1181 
Coupling digesta to uptake and transport models of the intestinal epithelium 1182 
More recently, human enterocyte cell culture models (such as Caco-2 cells) was 1183 
coupled with a simulated gastric model. Small intestinal digestive processes or 1184 
following further colonic fermentation have been widely used as a predictive tool for 1185 
the absorption of bioactive components from foods (Chitchumroonchokchai and Failla 1186 
2006). Caco-2 is a cell line originating from human colonic carcinoma that exhibits 1187 
some morphological and functional characteristics similar to those of differentiated 1188 
epithelial cells that line the intestinal mucosa (Sambruy and others 2001). The in vitro 1189 
digestion/Caco-2 cell culture model developed by Glahn and others (1998) offers a 1190 
rapid, low-cost method for screening foods and food combinations for iron uptake 1191 
before more definitive human trials (Hur and others 2011). Most Caco-2 cell model 1192 
studies were carried out to model iron uptake and many researchers reported that the 1193 
estimation of iron bioavailability, but also that of other phytochemicals such as 1194 
carotenoids from the in vitro digestion/Caco-2 cell culture model has been well 1195 
correlated, qualitatively and quantitatively, with human data (Garrett and others 1999; 1196 
Mahler and others 2009). Caco-2 cells have also been applied to a number of uptake and 1197 
transport studies for both hydrophilic constituents (such as polyphenols) and lipophilic 1198 
compounds (such as carotenoids).  Garret and others (1999, 2000) developed a coupled 1199 
digestion/Caco-2 human intestinal cell system to examine cellular acquisition of 1200 
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micellarized carotenoids and other lipophilic components from digested foods, 1201 
supplements, and meals. While the majority of studies have focused on simple uptake 1202 
employing a biphasic model with the apical membrane and the cell layer, uptake models 1203 
including also an additional basolateral compartment are also available to allow the 1204 
study of fluxes and, therefore, kinetic parameters through the cell layer (Reboul and 1205 
others  2006; Manzano and Williamson 2010; Biehler and others  2011a). However, the 1206 
latter requires transwell inserts, which are more costly, and the concentrations to be 1207 
determined are usually lower and may require more sophisticated analytical instruments 1208 
for detection, such as mass spectrometry, and may not be feasible for easily studying 1209 
minor food constituents. More detailed discussion on characteristics and limitations of 1210 
standard in vitro digestion methods coupled with a Caco-2 cell model can be found in 1211 
review articles by Failla and others (2008a) and by Biehler and others (2011a).  More 1212 
recently, the Caco-2 cell model has been extended by adding a layer of mucus-1213 
producing cells (such as HT-29 MTX cells) on top of the Caco-2 cells. However, only 1214 
preliminary data are available on how this system performs compared to Caco-2 cells 1215 
alone, although this may represent a more realistic approach, which may further hamper 1216 
uptake of more lipophilic constituents due to the additional mechanical barrier 1217 
(Nollevaux and others 2006). Also, Ussing chambers are used, in order to obtain a better 1218 
understanding of the transepithelial transport processes on a molecular basis. This is a 1219 
model that simulates the mucosa and its luminal/apical side (Bergmann H and others 1220 
2009; Clarke LL 2009). For example, Deusser H and others (2013) have used the 1221 
Ussing chamber to evaluate apple polyphenol transport and their effect on mucosal 1222 
integrity.  1223 
 1224 
Conclusions and Summary  1225 
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 1226 
Many considerations have to be taken into account when determining 1227 
bioaccessibility of phytochemicals by means of in vitro digestion models. Two 1228 
important criteria are whether the focus of research is on  biochemical transformation of 1229 
food components and metabolomics, favoring the metabolic batch models, or if the 1230 
close simulation of dynamic physiological conditions and changes in microbial 1231 
population are the primary aims, the use of continuous models such as the TIM models 1232 
can be recommended. An additional criterion is the lipophilicity of the phytochemicals 1233 
of interest. While for hydrophilic compounds such as for polyphenols, often associated 1234 
with fiber or complex carbohydrates, amylase digestion and perhaps particle size appear 1235 
to play predominant roles. Whereas, for lipophilic compounds, (such as carotenoids) 1236 
emulsifying agents, (presence of dietary fats, bile salts, and sufficient lipolytic activity), 1237 
appear crucial, thus their use during digestion should be well considered and 1238 
standardized. This includes adjusting pH values and sufficient digestion times to allow 1239 
for optimal enzyme functioning comparable to the in vivo situation. The suggested 1240 
conditions for static digestion models are outlined in Table 5. In addition, lipophilic 1241 
phytochemicals require separation of the micellar fraction prior to further investigation, 1242 
such as via ultracentrifugation (static model), filtration, or employing a membrane 1243 
(dynamic model). Coupling the cell-based uptake model with large intestinal digestion 1244 
model is a comparatively novel but important completion of modeling digestion. This 1245 
may especially be suitable for compounds such as polyphenols, which are metabolized 1246 
and taken up from the colon.  1247 
Until now, the lacking of consensus values for the different digestion parameters has 1248 
hampered the possibility to compare results across different studies. The suggested 1249 
conditions are based in relevant in vivo data, yet further studies should be done to 1250 
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validate its use and limitations in phytochemicals digestion. While still having their 1251 
limitations, much insightful information has been gained from applying in vitro 1252 
digestion models to phytochemical research. The recent improvements in our 1253 
understanding and the advances in the technology warrant continuous research in the 1254 
important area of bioavailability. 1255 
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Table 1: Concentrations of enzymes and concentrations employed during the oral phase of in vitro (A) and human studies in vivo (B) studies. 2017 
A - in vitro studies 
Type of study α-Amylase activity (U/mL)* 
pH of 
digestion 
Time of 
digestion (min) Temperature (º C) Study/reference 
Digestion of grape seed 
flavonoids (human saliva) Not specified 6.9 10 37 (Laurent and others2007) 
Digestibility of soya bean, 
cowpea and maize ca. 1 7 30 37 (Kiers and others2000) 
Bioactivity of wheat bread; 
changes in the antioxidant 
activities of vegetables 
200 6.75 10 37 (Gawlik-Dziki, 2009, 2012)  
Developing digestion procedure 
with mammalian enzymes 25-125 7 15 37 (Lebet and others1998) 
ß -Carotene micellarization  900 6.5 ±0.2 10  37 (Thakkar and others 2007) 
ß -Carotenoid bioacessibility 300 6.7-6.8 10-15 37 (Bengtsson and others 2009, 2010 
ß -Carotene bioaccessibility 
(human saliva from n=9) 12.5
e 6.7-6-9 10 37 (Schweiggert and others 2012) 
ß-Carotene bioaccessibility 
from sweet potato 35 7.0 10 37 (Poulaert and others 2012) 
Polyphenol release during 
digestion 150 6.9 10 37 (Tagliazucchi and others 2012)  
 2018 
 2019 
 2020 
 2021 
 2022 
 2023 
 2024 
 2025 
 2026 
 2027 
 2028 
 2029 
 2030 
 2031 
Table 1 cont. 2032 
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  B - Human studies (in vivo)  
Type of study -Amylase activity (U/L)** Time of digestion (min) 
pH Study/reference  
Studying impact of saliva process on 
lipophilic polyphenol availability Not specified 0.5 nd (Ginsburg and others  2012) 
 
Physiology of human saliva including 
mucin and electrolytes Not specified nd 7.0 (Aps and Martens, 2005) 
 
Human salivary α-amylase activity 
 4-1653, mean 284
e nd nd (Suska and others2012)  
List of reference values 60-282, mean 170f nd nd (Jakob, 2008; Kopf-Bolanz and others 2012)   
Stress and alpha-amylase 220-500 between 8am. and 20pm.f nd nd (Nater and others 2010) 
 
Oral digestion of cereals by humans 52-77(basal ) 58-66(with cereals)e 5 7.1±0.1 (Hoebler and others 1998) 
 
Saliva activity measurements 190f nd nd (Rohleder and Nater, 2009)  
 2033 
 2034 
 2035 
*”Sigma units”, unless stated otherwise: 1 unit will liberate 1 mg maltose from starch in 3 min at 20 °C at pH 6.9. Often done via the dinitrosalicylic acid (DNS) color assay (540 nm). 2036 
Conversion to IFCC and Phabedas: when expressed as same mass unit (mmol not mg), 1 DNS unit = ca. 2.5 IFCC units (Bassinello and others 2002). For results given in mg, conversion factor 2037 
from DNS to IFCC is x 2.5/342 = x 0.0073.   2038 
** Units are expressed here in final volume of salivary fluid. 1 unit will cleave 1μmol glucosidic linkage from starch per min, however substrate may differ. Both methods presented here (IFCC 2039 
EPS and Phabedas) yield comparable results  2040 
e: Phabedas (Magle AB, Lund, Sweden) test: blue color from starch breakdown measured at 620 nm. Conversion from µkat to U according to 2041 
http://www.phadebas.com/data/phadebas/files/document/Instructions_Phadebas_Amylase_Test.pdf, 60U=1µkat 2042 
f releases 1 µmol/min p-nitrophenol from 4,6-ethyliden-G7-p-nitrophenol-D-maltoheptasoid (ethylidene-G7PNP , measured at 405 nm. 60 U=1 µkat (IFCC EPS method, Ethylen protected 2043 
substrate) 2044 
 2045 
 2046 
 2047 
 2048 
 2049 
 2050 
 2051 
Table 2: Typical concentrations of gastric enzymes in human studies and in vitro experiments.  2052 
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A - In vitro studies 
 
Type of study Pepsin* (mg/mL) 
Pepsin activity* 
(U/mL) 
pH of 
digestion 
Time of 
digestion (min) 
Study/reference 
Bioavailability of iron ca. 5 4,000-12,500 2.0 120 (Miller  and others 1981) 
Bioaccessibility of carotenoids 2.3 1,800-5,600 2.0 60 (Biehler  and others 2011a, b) 
Bioaccessibility of carotenoids 2.2 1,700-5,400 2.0 60 (Garrett  and others 1999) 
Bioaccessibility of carotenoids 1.7 1,400-4,300 2.0 60 (Hedrén and others 2002) 
Bioaccessibility of carotenoids 1.2 900-3,000 4.0 30 (Dhuique-Mayer  and others 2007) 
Bioaccessibility of carotenoids 1.0 800-2,500 2.0 60 (Liu and others 2004) 
Bioaccessibility of carotenoids 3.0 2,400-8,300 2.0 60 (Yonekura and Nagao 2009)  
Bioaccessibility of polyphenols nd 315-350 2.0 120 (Gil-Izquierdo and others 2002) 
Bioaccessibility of polyphenols 2.2 1,800-5,600 2.0-2.5 60 (Bouayed  and others 2011) 
Bioavailability of polyphenols 16 15,600 2.0 120 (Cilla and others 2011) 
Bioavailability of polyphenols nd 158 2.0 120 (Tagliazucchi and others 2012) 
Bioavailability of polyphenols ca. 0.1 315 1.7 120 (McDougall and others 2005a, b) 
 2053 
 2054 
 2055 
 2056 
 2057 
 2058 
 2059 
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Table 2 cont. 2060 
B- Human studies (in vivo) 
 
 
Fluid investigated and type of study Pepsin (U/mL) 
Gastric residence 
time (h) 
pH Study/reference  
Digestion of adults 942$ (1207)*(basal) nd nd (Armand and others1995)  
Digestion of infants ca. 85
$ (109)* (pp)
190$ (243)* (basal) nd nd (Armand and others1996a) 
 
Helicobacter pylori impact on stomach 47b (174)* nd 1.41 (basal) (Feldman and others 1998)  
18 individuals, fasting juice 37±21 [7-70]a (3700)* nd 1-4, median 2 (basal) (Ulleberg and others 2011)  
Pepsin inhibitors in humans 20-260 µg/mL& nd nd (Pearson and Roberts, 2001)  
Measurement gastric secretion nd nd 
1.1 (basal); 
3.5 (60 min. pp) 
2.0(120 min. pp) 
(Gardner and others 2002) 
 
Characterization of digestive fluids 110-220 µg/mL (basal)
& 
260-580 µg/mL (pp) nd 
2 (basal) 
6 (60 min. pp) 
5 (120 min. pp) 
(Kalantzi and others 2006) 
 
Helicobacter pylori impact on pepsin 114 to 1030 µg/mL& nd 2.4 (basal) (Newton and others 2004)  
Gastric residence time, solid meal nd 3.5± 0.7 nd (Mojaverian and others 1988)  
Gastric residence time of capsule nd 1.2± 0.45 
 
1.5±0.04 (basal) 
 
(Mojaverian, 1996) 
 
Gastric passage time of capsule nd 1.0 nd (Worsoe and others 2011)  
Digestability of rice pudding nd 65% com-plete (1.5h) nd (Darwiche and others 1999) 
 
*”Sigma units”, pepsin typically used: 800 – 2500 units/mg such as by Sigma-Aldrich. 1 unit: One unit will produce a change in absorbance of 0.001 at 280 nm at 37 oC, in 1 min, at pH 2.0, 2061 
with hemoglobin as substrate. 2062 
$ IN VITROOne pepsin unit has been defined as the amount of enzyme required to produce 0.1 μmole of tyrosine-containing peptides at 37 °C in 10 min at pH 1.8 from a 2% hemoglobin 2063 
solution. 1 unit equivalent to approx. 1.28 “Sigma units” (http://www.worthington-biochem.com/pm/assay.html).  2064 
a One unit of enzyme activity was defined as the amount (in mL) of gastric or duodenal juice giving a difference in absorbance of 1.0 at 280 nm at 37 °C and pH 3.0, in 10 min, with hemoglobin 2065 
as substrate. 1 unit equivalent to approx. 100 “Sigma units”.  2066 
b measured as international units, with 1 IU=3.7 Anson units.    2067 
nd= no data;  pp=post-prandial; & µg enzyme/mL  2068 
Table 3: Concentrations of intestinal enzymes and bile salts in humans studies and in vitro experiments.  2069 
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 2070 
A - In vitro studies 
 
Type of study 
 
Bile salts+ 
(mmol/L) 
Pancreatin* 
concentration, ca. 
(mg/L) 
Minimum 
pancreatin 
activity (U/mL)*
pH Digestion time 
(min) 
Study/reference 
Bioaccessibility  of  iron ca. 4  
(2 g/L) 
300 2.4 7.5 150 (Miller and others  1981) 
Bioaccessibility  of 
carotenoids 
ca. 8.6 
 (4.3 g/L) 
720 5.8 7-7.5 120 (Biehler and others  2011b) 
Bioaccessibility  of 
carotenoids 
12  
(6 g/L) 
2500 20 7.5 120 Yonekura and others  2009) 
Bioaccessibility  of 
carotenoids 
4.4  
(2.1 g/L) 
390 3.1 7.5 120 (Garrett and others  1999) 
Bioaccessibility  of 
carotenoids 
7.5 
 (3.75 g/L) 
600 4.8 7.5 30 (Hedrén and others  2002) 
Bioaccessibility   of 
carotenoids 
2.8  
(1.44 g/L) 
240 2.0 6.0 30 (Dhuique-Mayer and others  2007) 
Bioaccessibility  of 
carotenoids 
3.0  
(1.5 g/L) 
250 2.0 ca. 7 120 (Liu and others 2004) 
Bioaccessibility of 
polyphenols 
3.0 
(1.5 g/L) 
250 2.0 5 to 7.5 120 (Gil-Izquierdo and others 2002) 
Bioaccessibility  of 
polyphenols 
4.3 
(2.2 g/L) 
360 2.9 6.5→7.0-7.5 165 (Bouayed  and others 2011) 
Bioaccessibility  of 
polyphenols 
44 
 (22 g/L) 
3,600 29 6.5 120 (Cilla and others  2011) 
Bioaccessibility  of 
polyphenols 
10 
(5 g/L) 
800 6.4 7.5 120 (Tagliazucchi and others2012) 
Bioavailability of 
polyphenols 
10 
(5 g/L) 
800 6.4 
 
nd 
120 
(McDougall et al., 2005a, b) 
 2071 
 2072 
 2073 
 2074 
 2075 
 2076 
Table 3 cont.  2077 
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B - Human studies (in vivo) 
 
Fluid investigated and type of 
study 
 
pH 
Bile salts 
(mmol/L) 
Lipase activity  (U/mL) Study/reference 
Duodenal fluids;  
jejunal fluids; 
7.00.4 
6.80.4 
0.6 - 5.5 (fasted) n.d. (Perez de la Cruz Moreno and others 2006) 
Duodenal fluids  nd 3.8–11.8 (fed) 
(2-6 g/L) 
n.d. (Van Deest and others 1968) 
Duodenal fluids (standard meal) nd. 5 – 10 (fed) n.d. (Tabaqchali and others 1968) 
Duodenal fluids (standard meal) 5.5-8.0, mean 
6.5 
20 (fed)
(2–18 g/L) 
15-120 (fed) (mean 50)& (Borgstrom and others 1957) 
Review article nd 4 – 20 (fasted) n.d. (Garidel and others 2007) 
Orlistat and enzyme activity 6-6.5 n.d. 1000 (fed)e 
(0.6 g/L) 
(Sternby and others 2002) 
Pancreatic enzyme examinations. nd n.d. 70-1000, mean 300& (Braganza and others1978) 
Duodenal fluids (after regular diet) n.d. n.d. 10 (fasted), 130 (fed)& (Dukehart and others 1989) 
Review lipolysis n.d. 3-7 (fasted) 
5-15 (fed) 
150-300& 
 
(Patton and Carey 1981; Zangenberg and others 2001a, b) 
Fasting 
18 individuals 
5-9, mean 7 2.71.3 
(fasted) 
units not comparable to other tests (Ulleberg and others, 2011) 
 
Duodenal fluids 
6-14 individuals 
(median) 
6.2 (fasted) 
5.2-6.6 (fed) 
2.6 (fasted) 
11.2 (fed 30 min) 
5.2 (fed 180 min) 
n.d. (Kalantzi  and others2006) 
Duodenal fluids 
Test meal 
6.0-7.0 5.9±1.8 (fasted) 
6.7-13.4 (fed) 
600 (fasted)e 
1200-1400 (fed)e 
(Armand  and others1996b) 
Duodenal juices 
Meal - Review 
n.d. n.d. 80-7000e (Armand, 2007) 
Small intestinal transit time (min) 90 (Kim, 1968) 
GI passage times (min) 197 (Degen and Phillips, 1996) 
GI passage times (min) 199 (Yu and others1996) 
 2078 
*Pancreatin typically used: 4 x US Pharmacopoeia specifications (2 USP units (U) lipase), 8 units; and both 25 USP, 100 USP units protease and amylase. Definition lipase: 1 2079 
unit liberates at least 1 µmole acid from olive oil/triolein per minute at 37 oC and pH 9 (http://www.pharmacopeia.cn/v29240/usp29nf24s0_m60320.html). Definition 2080 
protease: hydrolyses casein at an initial rate such that there is liberated per min an amount of peptides not precipitated by trichloroacetic acid that gives the same absorption at 2081 
 
 
79 
280 nm as 15 nmol of tyrosine (http://www.pharmacopeia.cn/v29240/usp29nf24s0_m60320.html). Definition amylase: decomposes starch at an initial rate such that 0.16 2082 
umol of glycosic linkage is hydrolyzed per min at pH 6.8 (and conditions further described for the amylase assay, 2083 
http://www.pharmacopeia.cn/v29240/usp29nf24s0_m60320.htm).    2084 
& same as USP units.  2085 
e Tributyrin units: 1 TBU (lipase unit) is the amount of enzyme which releases 1 mmol titratable butyric acid per min at 40 oC, pH 7.5. Yields comparable results to triolein units when 2086 
expressed at same unit of molarity (McCoy and others 2002). 2087 
+ values calculated from weight assuming a molecular weight of 500 g/mol and 100% purity.  2088 
$postprandial2089 
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Table 4: Microbial phenolic metabolites identified from in vivo human studies and in vitro colonic models. 
Food Metabolites in vivo Reference Metabolites in vitro Colonic model  Reference 
Tea 
 
1.3-Dihydroxyphenyl-2-O-sulfate 
5-(3′,4′-Dihydroxyphenyl)-γ-valerolactone 
5-(3′,4′,5′-Trihydroxyphenyl)-γ-valerolactone 
Hippuric acid  
1,3-Dihydroxyphenyl-2-O-sulphate 
 
(Daykin and 
others 2005) 
3-Phenylpropionic acid 
3-(3’,4’-Dihydroxyphenyl) propionic acid 
3-(3-Hydroxyphenyl)propionic acid 
3-Hydroxyphenylacetic acid 
2,6-Dihydroxybenzoic acid 
1,2,3-Trihydroxyphenol 
 
Batch  
Time: <72 h 
pH: 7.15±0.07 (start), 
6.92 ±0.26 (end) 
(Gross and 
others 2010) 
   3-Phenylpropionic acid 
5-(3′,4′-Dihydroxyphenyl)-γ-valerolactone 
3-(3’,4’-Dihydroxyphenyl) propionic acid 
3(4-Hydroxyphenyl)propionic acid 
SHIME1 Stomach, 
small intestine and 3-
colonic vessels dynamic 
model (pH 5.6-5.9, 6.1-
6.4 and 6.6-6.9).  
Time: 2 weeks 
(continuous) 
 
(Van 
Dorsten and 
others  
2012) 
Red wine, 
grapes 
 
 
3-(3-Hydroxyphenyl)-propionic acid 
3-Hydroxyphenylacetic acid 
3,5-Dimethoxy-4-hydroxybenzoic acid 
3-Hydroxyhippuric acid 
Hippuric acid 
4-Hydroxyphenylacetic acid 
 
(Jacobs and 
others 2012) 
 
3-(3-Hydroxyphenyl)-propionic acid 
3- and 4-Hydroxyphenylacetic acid 
5-(3′,4′-Dihydroxyphenyl)-γ-valerolactone 
γ-Valerolactone 
 
Batch  
pH: 6.8  
Time: 48 h 
 
 
 
(Sanchez-
Patan and 
others 2012) 
 
 
 
  
  
 
 
3-(3’,4’-Dihydroxyphenyl) propionic acid  
2-(3’,4’-Dihydroxyphenyl) acetic acid 
5-(3’-Hydroxyphenyl) pentanoic acid  
3,5-Dimethoxy-4-hydroxybenzoic acid 
3-Methoxy-4-hydroxybenzoic acid 
 
Batch  
pH: monitored at each 
time point  
Time: 0, 2, 4, 6, 8, and 
24h 
 
(Aura and 
others  
2012; Gross 
and others 
2010) 
 
Chocolate, 
cocoa 
3-(3-Hydroxyphenyl)-propionic acid 
5-(3,4-Dihydroxyphenyl) valerolactone and 
conjugates 
5-(3,4-Dihydroxyphenyl) valerate conjugates 
4-Hydroxy-5-(3,4-dihydroxyphenyl)valeric acid  
Phenylvalerolactone derivatives 
 
(Llorach and 
others 2009) 
3-(3-Hydroxyphenyl)-propionic acid 
3-Hydroxyphenylacetic acid  
3,4-Dihydroxybenzoic acid 
 
3-Colonic vessels 
dynamic model  
pH: 5.5, 6.2 and 6.8  
Time: 36 h 
(Fogliano 
and others 
2011) 
Soy O-Demethylangolensin,  
Equol 
Dihydrogenistein 
(Joannou and 
others 1995) 
O-Demethylangolensin,  
Equol  
 
Batch  
Time: 72 h 
 
(Possemiers 
2007)  
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   3-Methoxy–4-hydroxyphenylacetic acid 
4-Hydroxyphenyl acetic acid 
TIM2-2 colonic 
dynamic model  
pH: 5.8, 6.4 and 7.0 
time: <28 h 
 
(Gao and 
others 2006) 
Berries, 
nuts 
4’-Hydroxymandelic acid,  
3’,4’-Dihydroxyphenylacetic acid 
3-(4’-hydroxyphenyl)lactic acid 
4’-Hydroxyhippuric acid 
Hippuric acid 
Urolithins 
(González-
Barrio and 
others2011) 
 
 
4-Hydroxybenzoic acid 
3,4-Dihydroxybenzoic acid 
3-(3’-Hydroxyphenyl)propionic acid  
3-(3’,4’-Dihydroxyphenyl)propionic acid 
3-(4’-Hydroxyphenyl)lactic acid 
Urolithins 
Batch Time: <72 h 
pH: 7.2 (start), 6.2 (end) 
(González-
Barrio and 
others2011)  
 4-Hydroxy-5-(phenyl)valeric acid conjugates 
Vanillic acid glucuronide 
Hydroxyhippuric acid  
Ferulic acid glucuronide 
1,3-Dihydroxyphenyl-2-O-sulfate 
Urolithin A and B conjugates 
 
(Tulipani and 
others2011) 
 
   
Citrus 
fruits 
4-Hydroxy-phenylpropionic glucuronide 
4-Hydroxy-benzoic acid glucuronide 
3-Methoxy-4-hydroxy-phenylacetic glucuronide 
3- and 4-Hydroxyphenylacetic glucuronide 
Hippuric acid glucuronide 
(Vallejo and 
others 2010) 
3-Methoxy–4-hydroxyphenylacetic acid  
4-Hydroxyphenyl acetic acid 
3,4-Dihydroxyphenylacetic acid  
3-(3-Hydroxyphenyl) propionic acid  
3-(4-Hydroxy–3-methoxyphenyl) 
propionic acid  
3-Hydroxyphenyl acetic acid 
Hippuric acid. 
TIM-2 colonic dynamic 
model  
pH 5.8, 6.4 and 7.0.  
Time: <28 h 
(Gao and 
others 2006) 
  
 
 
1SHIME, Simulator of the Human Intestinal Microbial Ecosystem (Molly and others 1993).   
2TIM, TNO Intestinal Model (Minekus 1995). 
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Table 5: Summarized conditions for simulated digestion under static conditions, based 1 
on common in vitro conditions applied, feasibility, and their similarity to in vivo 2 
conditions 3 
 4 
Phase of digestion  Common in 
vitro values* 
Common in vivo 
values* 
Tentatively 
suggested** 
Oral phase 
-α-amylase (U/mL)a 
  
110 
 
26 
 
25-200 
-time (min)  10 0.5-5 1-5 
-pH  6.9 7.1±0.1 7.0±0.2 
Gastric phase 
-pepsin (U/mL) b,d 
  
1,400-4,300 
 
170-1200;  0.1-0.2 g/L 
 
5,000-10,000 
-time (min)  60 60-72;140-210c 60; 120c 
-pH  2.0 2 (fasted); 3.5 (120 min 
(fed)+) 
3.5±0.5 
Small intestine 
-lipase$ 
  
4.0 
(0.5g/L) 
 
70-1000 (fed);  
10 (fasted) 
 
20-200 
-bile salts (mmol/L)  7.5 
(3.8 g/L) 
5 (fasted) 
10 (fed)+ 
10 
-time (min)  120 200 120-200 
-pH  7-7.5 6.8±0.4 7±0.2 
Large intestine 
-time (min) 
  
42 (24-72) 
 
35±2.1 
 
35-45 
-pH  6.6 (5.5-7.2, start) 
6.6 (end) 
6.2 (5.7-6.7) 6.2-6.6 
 5 
*median value taken from Tables 1, 2, 3, and 4 6 
**taking into account human trials (Tables 1, 2, 3 and 4) and herein reported physiological values 7 
a ”Sigma units”(see Table 2). For conversion into IFCC units x 0.0073 (i.e. 140 units  = 1.02 IFCC units).  8 
b ”Sigma units:” Pepsin typically used: 800 – 2500 units/mg such as by Sigma-Aldrich. 1 unit: One unit will produce 9 
a change in absorbance of 0.001 at 280 nm at 37 oC, in 1 min, at pH 2.0, with hemoglobin as substrate. See footnotes 10 
table 2 for conversion factors.  11 
c liquid and solid meals, respectively 12 
d gastric lipase not required for water soluble compounds, however for lipophilic compounds such as carotenoids a 13 
concentration of 40-80 U/mL is recommended (Armand 1999, 2007). Gastric lipase (tributyrin units): 10-65 (mean 14 
40, Armand 1999); 60-80 (Armand 2007). 1 TBU (lipase unit) is the amount of enzyme (g) which releases 1 mol 15 
titratable butyric acid per minute under the given standard conditions.   16 
+ post-prandial 17 
$1 unit liberates at least 1 µmole of acid from olive oil/triolein per minute at 37 oC and pH 9. Comparable to tributyrin 18 
units when expressed at same molarity.  19 
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Figure 1: Decision tree for choosing an in vitro digestion models: Some a-priori 
considerations. Major aspects concern lipophilicity of the phytochemical, as well as amount 
sample material and number of samples.  
What is the 
research 
What type of 
phytochemicals? 
What is the 
research 
Hydrophilic 
(e.g.polyphenols) 
Lipophilic or both  hydro+lipophilic 
 (e.g carotenoid or carotenoid+polyphenols) 
Screening/comparing, 
hypothesis building 
Screening/comparing, 
hypothesis building 
Confirmatory and 
sophisticated/physiological 
testing 
Confirmatory and 
sophisticated/physiolog
testing 
Number of 
samples? 
Static  Dynamic  
Number of 
samples?
Considerable 
number Few 
Static   Dynamic   
Considerable 
number Few 
 +Lipid to test meal; 
 Ultracentrifugation/fi
ltration  
 +Lipid to test meal; 
 Membrane (e.g. TIM 
LIPID) for studying 
micellar fraction 
Degradation 
products? 
Outputs adequate to 
the research 
question? 
Consider dynamic model 
or additional modifications 
Dynamic   
- +Lipid to test meal; 
Bioaccessibility? 
No 
